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The liver is one of the most essential organs in human body. However, the 
embryonic development of the liver has not been well understood. In this project we 
utilized zebrafish, Danio rerio, as a model organism to study genes which are 
involved in liver organogenesis via genetic approach.  
Firstly, forward genetic screening was applied to identify zebrafish mutants with 
smaller or invisible liver, which could be signs of defects in hepatogenesis or hepatic 
outgrowth. 71 putative liver defect mutants, which came from 54 F2 families, were 
obtained initially. Subsequently, outcross and preliminary characterization narrowed 
our scope to 15 individual lines which have no major general defects except for 
small-liver or no-liver phenotype. These mutant lines are valuable resources for the 
cloning of genes important for liver development. 
Secondly, one of the small-liver mutant sec13sq198 was selected for positional 
cloning of the mutated gene. The mutation site was identified to be within the sec13 
gene in linkage group 22. It is an intronic thymine to adenine transition, which creates 
a new splicing receptor site and results in a carboxyl-terminal truncated protein as 
confirmed by western blot.  
Thirdly, detailed phenotype characterization of the mutant phenotype was 
performed. Whole mount mRNA in situ hybridization with organ specific as well as 
pan-endoderm probe suggested that the liver specification, budding and initial growth 
is not affected in the homozygous mutant. However, the expansion growth of the liver, 
as well as other digestive organs such as the intestine and pancreas, is arrested after 3 
dpf. Furthermore, impaired development of skeleton cartilage was also observed as 
revealed by alcian blue staining. 
Finally, functional study of the truncated gene product, Sec13sq198, was carried 
out in both zebrafish and human cell line. Sec13 was known to interact with Sec31A 
to form the out layer of the COPII complex, which is essential for the protein and 
lipid transport from ER to Golgi. Sectioning immuno-staining revealed that Sec13 and 
Sec31A express at high level in zebrafish liver, intestine, exocrine pancreas and 
skeleton cartilage cells. Cellular localization study in Hela cells and 
co-immunoprecipitation analysis in 293T cells indicated that Sec13sq198 failed to 
interact with Sec31A. In addition, although Sec13 level is constant in all embryonic 
  x
stages in zebrafish, Sec31A is not detectable prior to 2 dpf by western blot. 
Transmission electron microscopy revealed a misplacement of ECM and a disrupted 
ER and Golgi structure in mutant skeleton cartilage cells, which indicated defects in 
secretory pathway. 
Combine all data in our hands, we propose that the loss-of-function sec13sq198 
mutation disrupts the proper COPII mediated protein transportation in zebrafish 
embryo and that causes the growth arrest in the liver, the intestine, the pancreas and 
the skeleton cartilage. 
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Chapter 1. Introduction 
1.1  Principles of developmental biology 
Almost all multicellular living beings undergo sexual reproduction start from a 
single fertilized egg, or zygote. Mitosis division of the zygote initiates a series of slow 
and progressive changes, such as the arising of germ layers, proliferation of cell 
linages and subsequent formation of different tissues and organs. This process does 
not stop at birth but lasts for the whole lifespan of the organism. We usually address 
this process as developmnet, which ensures the existance and reproduction of 
organisms. Developmetnal Biology concentrates on the amazing and dynamic 
changes during the development process. It is a science about becoming rather than 
being. It investigates the formation of organisms rather than their structure and 
maintenance. Developmental biology consists six general aspects.  
1) Differentiation: how hundreds of cell types arise from a single cell with the 
same genetic material;  
2) Morphogenesis: how the differentiated cells are organized in a predetermined 
order to form and arrange intricate tissues and organs;  
3) Growth: how the division of numerous cells in hundreds of types is regulated 
in a concert;  
4) Reproduction: how the male and female gametes are set apart and instructed to 
form the zygote;  
5) Evolution: how the changes in development are inherited to the next 
generation;  
6) Environmental integration: how the development of an organism is affected by 
its habitat variation. 
To study these topics, scientists need to coordinate different subjects of biology, 
from molecular biology and biochemistry to cell biology and physiology, further to 
the system biology, ecology and evolution. Traditionally, there are three major ways 
to study developmental biology. The earliest is anatomical approach, which gave rise 
to experimental approach. Genetic approach was built based on anatomic and 
experimental approaches. Recently, molecular genetics has begun to integrate these 
approaches to produce a vigorous and multifaceted science of development biology. 
A multicellular organism before birth is usually refered to as an embryo. It is 
developed from a zygote through distint stages of morula, blastula, gastrula and 
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organogenesis, which in a whole is named embryogenesis. Figure 1-1 illustrates the 
stages of developmental history of zebrafish. After fertilization, the zygote 
immediately undergoes a series of extremely rapid mitotic divisions, which is called 
embryonic cleavage, and divides into thousands of smaller cells, the blastomeres. By 
the end of the cleavage, the newly generated blastomeres form a sphere and the 
embryo at this stage is called morula. The mitotic divisions of blastomeres slow down 
after morula stage. Instead they start the arrangement of their positions which is called 
as gastrulation. Gastrulation results in the establishment of the three germ layers, the 
ectoderm, the endoderm, and the mesoderm. The cells of three germ layers will then 
start to rearrange to form tissues and organs in a process called organogenesis, which 
will last until the hatching or birth of the embryo.  
 
 
Figure 1-1. Developmental history of zebrafish. The stages from fertilization through hatching 
(birth) are known collectively as embryogenesis. Gametogenesis, which is completed in the sexually 
mature adult, begins at different times during development, depending on the species. (The sizes of the 
varicolored wedges shown here are arbitrary and do not correspond to the proportion of the life cycle 
spent in each stage.) Adapted from Developmental Biology, 6th edition, page 40. (Gilbert, 2000) 
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After hatching or birth there will be two kinds of cells in the body, the germ cells, 
which are set aside and exclusively responsible for reproduction, and the remaining 
somatic cells. The germ cells include gametes (sperms and eggs) and their antecedent 
cells. The formation of gametes from their precursors is called as gametogenesis. 
After maturation, the gametes may be released to form a new embryo, thus a new life 
cycle is started.(Gilbert, 2000) 
 
1.2  The structure and functions of the liver 
The liver is a large internal organ that presents in all vertebrates. In adult human 
it is the largest parenchyma organ which consists of about one fiftieth of the total 
body weight. Liver is extremely important to the body and has many essential 
functions, including storage of substances, maintaining homeostasis, blood 
detoxification, producing numerous enzymes for metabolism, and serving as an 
endocrine/exocrine organ. In mammalian fetus, the liver is the initial site of 
hematopoiesis, thus embryonic liver defects will lead to severe consequences.  
As a big vascular organ, the liver serves as a reservoir for body fluids. The adult 
human liver has the storage of 10-15% of total blood volume, which can be released 
for lifesaving in emergency such as acute injury. Liver also stores a multitude of 
substances, including glucose in the form of glycogen, vitamin B12, iron and copper 
etc.  
The liver plays critical roles in carbohydrate metabolism, lipid metabolism and 
protein metabolism. Glucose is a critical energy source of the body and its level in 
blood must be maintained in a normal but narrow range. The liver transforms 
excessive glucose in the blood into glycogen through glycogenesis and stores it as 
energy backup when the concentration of blood glucose is higher than normal, or 
depolymerizes liver-stored glycogen via glycogenolysis and exports back into to all 
over the body through blood stream when blood glucose level is low. In 
circumstances that hepatic glycogen reserves become used up, the liver synthesizes 
glucose from amino acids, lactate or glycerol through gluconeogenesis to meet the 
body’s energy requirement.  
In lipid metabolism, the liver directly oxidizes triglycerides for energy producing. 
On the other hand, it is also responsible for the conversion of excessive carbohydrates 
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and proteins into fatty acids and triglyceride, and exports them to adipose tissue. The 
liver synthesizes large quantities of cholesterol and phospholipids, which are either 
packaged with lipoproteins and transport to the rest of the body, or excreted in bile as 
cholesterol or bile acids after converting.  
In protein metabolism, the most critical function of the liver is the deamination 
and transamination of amino acids. It converts non-nitrogenous parts into glucose or 
lipids and transforms the ammonia into urea to exit the body in urine.  
The liver has very important endocrine functions. It secretes lots of serum 
proteins, such as albumin, fibrinogen, prothrombin, as well as protein C, protein S and 
antithrombin. These substances are extremely essential in maintaining homeostasis of 
the body. The liver’s major exocrine function is to assist digestion. It generates large 
amounts of bile into the digestive tract via hepatic duct. Bile contains water, 
electrolytes and a variety of organic molecules including bile acids, which are critical 
for digestion and absorption of fats and fat-soluble vitamins in the small intestine.  
The liver collects and breaks down body wastes, including hormones such as 
insulin, hemoglobin as well as some toxic substances, from blood stream. The 
metabolites after breaking down are added to bile and thus eliminated from the body.  
The liver is also involved in phagocytic system and immune system. It generates 
macrophage to remove particulate materials and microbes in the human body. In the 
immune response, the reticuloendothelial system of the liver contains many 
immunologically active cells, acting as a 'sieve' for antigens carried to it via the portal 
system. 
The liver is among the few internal human organs which capable of natural 
regeneration of lost tissue. In mouse, whole liver can be generated from as little as 
25% of remaining (Michalopoulos and DeFrances, 1997). This is predominantly due 
to the nature of hepatocytes, which act as unipotential stem cells. There is also some 
evidence indicate the existence of bipotential hepatic stem cells, called oval cells, 
which can differentiate into either hepatocytes or cholangiocytes (bile duct cells).  
The functions of the liver are highly supported by its structure. In human, the 
liver is located in the right upper side of the abdomen, just below the diaphragm and 
right to the stomach. It exhibits a triangle shape, wide part on the right side of the 
body and extending to the left side. The human liver consists of two large lobes and 
two small lobes surrounded by a capsule like connective fibrous tissue, the Glisson's 
capsule. The liver has a unique dual blood supply. One is arterial supply which mainly 
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comes from the hepatic artery branching from the celiac trunk, bringing fresh 
oxygenated blood from the heart. Occasionally some or all of the arterial blood can 
come from other branches such as the superior mesenteric artery. The other is venous 
supply comes through the hepatic portal vein which is joined by the splenic vein, the 
inferior mesenteric vein and the superior mesenteric vein. It brings nutrient rich blood 
from the small and large intestines, the pancreas and the spleen. Blood leaving the 
liver is collected in the hepatic vein which drains directly into the inferior vena 
cava(Maton and Jean Hopkins, 1993). With such an arrangement, liver can process 
the nutrients and byproducts of food digestion and condition blood through 
detoxification and endocrine activities (Figure 1-2-A).  
At the cellular level, the liver consists mainly of hepatocytes, a polarized 
epithelial cell, which account for nearly 60% of all the liver cells and carry out the 
major functions of the liver. Kupffer cells, cholangiocytes, stellate cells and 
endothelial cells make up the rest cell population in the liver. Hepatic cells are 
organized into plates separated by vascular channels, the sinusoids (Geissmann et al., 
2005). This organization is supported by the reticulin (collagen type II) network. The 
sinusoids are lined by endothelial cells and sinusoidal macrophages (Kupffer cells) in 
a discontinuous, fenestrated fashion. The endothelial cells have no basement 
membrane and are separated from the hepatocytes by the space of Disse, which drains 
lymph into the portal tract lymphatics. Kupffer cells are scattered between endothelial 
cells. They are part of the reticuloendothelial system and phagocytose spent 
enthrocytes. Stellate cells, which are otherwise referred to as Ito cells, can also be 
found in the space of Disse and is responsible for the storage of Vitamin A and 
produce extracellular matrix and collagen. Hepatocytes have surfaces facing the 
sinusoids, called sinusoidal faces, and surfaces which contact other hepatocytes, 
called lateral faces. Bile canaliculi are formed by grooves on some of the lateral faces 
of hepatocytes. They are thin tubes that collect bile secreted by hepatocytes. The bile 
canaliculi merge and form bile ductules, which eventually join to common hepatic 
duct. Cholangiocytes are the epithelial cells of the bile duct. They are cuboidal 
epithelium in the small interlobular bile ducts, but become columnar and mucus 
secreting in larger bile ducts approaching the porta hepatis and the extrahepatic 
ducts(Housset et al., 1995). Cholangiocytes modify bile by water reabsorption and 
through secretion under the influence of secretin and somatostatin. This kind of cell 
alignment in the liver vascular structure maximizes the exposing of hepatocytes to 
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blood flow and the bile canaliculi, thus largely facilitates the liver to conduct its major 






Figure 1-2. The structure of the human liver. A. Anterior view of the human liver and its 
surround tissues and organs, taken from http://www.hepfoundation.org.nz/images/liver2.jpg.  B. The 





1.3  Liver organogenesis 
1.3.1 Descriptive overview 
The liver is such an important organ yet with a relatively small numbers of 
differentiated cell types. This characteristic has made the liver an attractive system for 
scientists to investigate organogenesis and tissue development for decades. Previous 
studies regarding liver organogenesis were mostly conducted in chick, quail, as well 
as mouse and rat model systems and have brought many perspectives to the field. 
Liver is an endoderm-derived organ and its developmental process is conserved 
among vertebrates (Haffter et al., 1996). Liver initiation starts from the definitive 
endoderm at the gastrulation stage (Zaret, 2001). In mouse embryo, gastrulation starts 
at around embryonic day 6.5 (E 6.5), in which the definitive endoderm appears like a 
single-cell thick epithelial sheet that covers the bottom surface of the developing 
embryo. Subsequent invagination of the anterior and posterior ends of the embryo 
generates the foregut and hindgut (Zaret, 2002). At around E 7, the developing mouse 
liver can be morphologically identified as an outgrowing bud of proliferating 
endodermal cells present in the left ventral floor (Douarin, 1975). At this early stage 
the liver bud is separated from the surrounding septum transversum mesenchyme 
(STM) by basement membrane (Medlock and Haar, 1983). Following the progressive 
disruption of the basement membrane, the pre-hepatic cells delaminate from the 
young bud and migrate into the surrounding STM to undergo rapid proliferation and 
differentiation (Douarin, 1975; Medlock and Haar, 1983). These pre-hepatic cells in 
STM are commonly referred to as hepatoblasts, which give rise to definitive 
hepatocytes and cholangiocytes (bile duct cells) and differentiate much further in fetal 
liver (Shiojiri et al., 2001). At the same stage, endothelial cells will invade the liver 
bud and form the vascular structure in the nascent liver. During liver morphogenesis, 
the hepatocytes become polarized. The apical domain of hepatocytes lines the 
channels between cells, called canaliculi, which connect to bile ducts and drain into 
intestine (Lemaigre and Zaret, 2004). The basal layer becomes juxtaposed to 
fenestrated endothelium that lines sinusoids, or tissue gaps, in which blood stream 
from the arterial and intestinal portal circulations flow through and reach the venous 
circulation. By these means, the developing liver becomes ready to perform its 
aforementioned tasks (Lemaigre and Zaret, 2004). 
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1.3.2 Mechanisms controlling early stages of liver development 
Previous morphological and genetic data suggested that liver organogenesis starts 
with establishment of definitive hepatoblasts. Next, hepatoblasts delaminate out of the 
epithelial layer to form a discrete liver bud and meanwhile undergo fast proliferation 
to increase the liver bud size. Finally, hepatoblasts differentiate into functional 
hepatocytes and biliary duct cells (Duncan, 2003; Zaret, 2002) (Figure 1-3). These 
early stages of liver developments are controlled delicately by a variety of 
mechanisms, including response to signaling molecules from adjacent tissues and also 
regulation by local transcription factors (Figure 1-4). 
 
1.3.2.1  Inductive signals from surrounding tissues lead to hepatic 
specification 
In early gastrulation stage, the ventral endoderm is surrounded by a variety of tissues, 
including the pre-cardiac mesoderm, septum transversum mesenchyme (STM) and 
also endothelial cells. Tissue grafting experiment in chick-quail chimera system 
(Douarin, 1975) and mouse model (Fukuda-Taira, 1981) suggested that the 
pre-hepatic endoderm need to be in close contact with the pre-cardiac mesoderm to 
acquire hepatic competency. This is consistent with morphogenic pattern during this 
stage, which results in the invagination of the foregut and juxtaposing of the ventral 
endoderm with the developing heart (Figure 1-3). To reveal the signaling molecules 
involved in this process, Jung et al isolated the ventral endoderm from 2 to 6 somite 
stage mouse embryos and cultured them in vitro. They found that fibroblast growth 
factors (FGF-1 and FGF-8) could induce hepatic competency without the presence of 
pre-cardiac mesoderm (Jung et al., 1999). However, since the pre-cardiac mesoderm 
is tightly associated with the STM which contains BMPs (bone morphogenic protein), 
Jung’s colleagues, Rossi et al argue that possible contamination of the STM could not 
be excluded. To explore this possibility, they used tissue sample from BMP4-/- mouse 
embryos together with inhibitors of BMPs and revealed that BMP signaling from the 
STM is also necessary for hepatic competency (Ross et al., 2001; Rossi et al., 2001). 
Combine with a concurrent report that the default fate of the ventral endoderm is to 
develop into pancreas, not the liver (Deutsch et al., 2001), Rossi et al claimed that 
BMPs and FGFs function in a combinational fashion to repress the pancreatic fate of 









Figure 1-3. Diagram illustrating stages of liver development. At gastrulation the definitive 
endoderm is rendered competent to follow a hepatic fate. After specification, a swelling of the ventral 
endoderm generates the liver bud. The pre-hepatic cells then delaminate from the foregut and migrate 
into the septum transversum. Concurrent with this phase of rapid proliferation is the hepatic cells 














In addition to these two mesodermal signals, it has also been reported that 
endothelial cells surrounding the early liver bud are necessary to support hepatic 
differentiation and morphogenesis. However, the signaling molecules behind this 
phenomenon are currently unclear. (Matsumoto et al., 2001). Furthermore, in addition 
to the mouse and avian system, a recent study in a zebrafish mutant revealed that prt, 
a previously unidentified Wnt2b homologue from the nearby bilateral mesoderm, 
positively regulate liver specification (Ober et al., 2006).  
 
1.3.2.2 Transcription factors involved in liver organogenesis 
Gene expression is largely regulated through transcriptional control. It is expected 
that specific transcription factors will play important roles during liver development.  
 
1.3.2.2.1 Foxa family proteins 
Foxa family proteins, which are also known as HNF3s (hepatic nuclear factor 3) , 
were initially identified as liver-enriched transcription factors (Lai et al., 1990) which 
can bind to the promoters of the genes encoding α1-antitrypsin and transthyretin in 
mammals (Herbst et al., 1991). They were shown to regulate a variety of regulatory 
and metabolic proteins expressed in liver (Lee et al., 2005a). Its three isoforms, foxa1, 
foxa2 and foxa3, are encoded by different genes which shares 85% sequence identity 
over their DNA binding domains “winged helix” (Kaestner et al., 1994), which 
consist of a helix-turn-helix motif flanked by two “wings” of polypeptide chains that 
make DNA contacts (Clark et al., 1993). All foxa mRNAs express in endoderm and 
later in endoderm-derived tissues, in which over 100 genes have been found to 
contain the foxa binding site (Cereghini, 1996). Gene targeting studies of foxa 
isoforms in mouse revealed that foxa1 null mouse embryo is perinatal lethal due to 
pancreatic defects, but the liver is apparently not affected (Kaestner et al., 1999). 
Foxa2 inactivation leads to defects in foregut morphogenesis and notochord formation. 
The Foxa2-/- embryo died shortly after gastrulation (Ang and Rossant, 1994; 
Weinstein et al., 1994). Foxa3 knockout does not cause liver phenotype and is not 
lethal. However, the absence of Foxa3 reduces the expression of liver genes, such as 
GLUT2 (Kaestner et al., 1998). In 2005, Lee et al generated conditional knock out 
mouse (foxa2LoxP/LoxP;foxa3-Cre) system in which Foxa2 depletion is restricted to 
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endoderm but not notochord. Combine this system with the Foxa1 knockout mice, 
they found that there is no evidence of liver bud formation in the 
foxa1-/-;foxa2LoxP/LoxP;foxa3-Cre mouse embryos, and endoderm from these mice 
could not acquire a hepatic fate even when they were cultured in vitro with exogenous 
fibroblast growth factor 2 (FGF2) (Lee et al., 2005a). These findings suggested that 
Foax1 and Foxa2 are required for the establishment of competency within the foregut 
endoderm at the onset of hepatogenesis. Besides, they also implicated that the 
cross-talks between signaling molecules and innate transcription factors is essential in 
early stages of liver development. 
 
1.3.2.2.2 Gata transcription factors  
The Gata family zinc finger transcription factors are named after their DNA 
binding sequence. They have six known family members, Gata1 to Gata6 (Lowry and 
Atchley, 2000). Gata1, Gata2 and Gata3 mainly involve in the hematopoiesis process 
while Gata4, Gata5 and Gata6 play similar roles as the Foxa proteins in endoderm 
organogenesis. In mammals, Gata4, Gata5 and Gata6 express in early endoderm and 
later in gut and gut-derived organs (Bossard and Zaret, 1998). Serpent (Srp), a 
Drosophila ortholog of Gata factors, was found to be essential in the differentiation 
and morphogenesis of the endoderm and gut (Rehorn et al., 1996). Gata4 has been 
shown to bind the albumin enhancer. Functional analysis indicated that the binding of 
Gata4 as well as Foxas could open compacted chromatin to allow their occupancy by 
transcription activators (Cirillo et al., 2002). Rojas et al demonstrated that Gata4 is a 
downstream effector of BMP signaling in the lateral mesoderm (Rojas et al., 2005). 
Study in zebrafish system implicated that gata5 is involved in gut and liver 
development by acting downstream of the nodal signaling pathway (Reiter et al., 
2001). In mouse, Gata6 deficient is embryonic lethal. In 2005, Zhao et al used a 
tetraploid embryo complementation strategy to generate viable gata6-null mouse 
embryo with wild-type extraembryonic endoderm tissue. They found that although 
gata6 is not necessary for hepatic specification, it is essential for hepatoblast 
proliferation and differentiation (Zhao et al., 2005). Interestingly, maybe just like 
foxa1 and foxa2, gata6 and gata4 together may also control the hepatic specification 
(Zhao et al., 2005). 
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1.3.2.2.3 Hex and prox1 
Hex and prox1 are two transcription factors that are essential for liver bud 
formation. Hex encodes a divergent homeobox transcription factor and is highly 
expressed throughout the ventral endoderm at the early headfold stage which is just 
prior to the initiation of hepatogenesis. In 10 somite stage mouse embryo, hex 
expression within the ventral endoderm becomes restricted to future sites of the liver 
and thyroid (Keng et al., 2000). Studies using Hex-/- embryos revealed that the liver 
bud failed to form and the expression of hepatic differentiation markers, such as 
albumin, were perturbed, which indicated that hex is essential for very early stages of 
hepatic development (Keng et al., 2000). However, the fact that a swelling of the 
endoderm can be detected, even though hepatic gene expression remains undetectable, 
suggests that specification of the hepatic lineage occurs. Also worth to mention is that 
the phenotype exhibited by hex-/- embryos is the earliest perturbation to hepatogenesis 
described so far (Duncan, 2003). 
The homeobox gene prox1 was originally cloned by homology to the Drosophila 
gene prospero (Oliver et al., 1993). At embryonic day 9.0-9.5 (E 9.0-9.5), prox1 
expression in mouse embryo is localized in the hepatic primordium and dorsal 
pancreatic bud. At E 10-10.5, prox1 expression is detected in the liver bud, gall 
bladder, and dorsal and ventral primordial (Sosa-Pineda et al., 2000). 
Immunofluorescence experiments with anti–β-galactosidase, anti-albumin and anti–α
-fetoprotein antibodies revealed that the prox1-expression cells are hepatocytes 
(Sosa-Pineda et al., 2000). Analysis of prox1-/- embryos found that at E 14.5 the livers 
of the mutant embryos were significantly smaller than those in controls (Sosa-Pineda 
et al., 2000). Moreover, although the mutants formed distinct liver lobes, the hepatic 
parenchymal cells were restricted to a central rudiment (Sosa-Pineda et al., 2000). 
Similarly, when embryos were examined at earlier stages, from E 10 to E 12.5, 
hepatoblasts were absent from the developing liver lobes, instead they remain 
clustered within a central core (Sosa-Pineda et al., 2000). The proliferation of prox1-/- 
hepatoblasts was remarkably reduced compared to controls, implying that the overall 
numbers of hepatoblasts were reduced in the mutant embryo (Sosa-Pineda et al., 
2000). Furthermore, at E 10 while control hepatoblasts were seen to migrate as cords 
into the surrounding septum transversum mesoderm, prox1-/- cells failed to delaminate 




Figure 1-4 Signals and tissue interactions regulate liver organogenesis. a. The ventral foregut 
endoderm gains the competence to develop into various tissues as a result of the expression of 
transcription factors in the endoderm. These include Foxa proteins, as well as signals that affect the 
endoderm, including bone morphogenetic proteins (BMPs) that emanate from the adjacent cells of 
septum transversum mesenchyme (STM). b. During tissue specification, fibroblast growth factor (FGF) 
signals from the cardiogenic mesoderm, perhaps in conjunction with Bmp signals from the STM, 
initiate the liver gene program in proximal endoderm, as well as blocking that for pancreas. Ventral 
endoderm cells sufficiently distal to the cardiogenic mesoderm escape the latter inhibitory effect and 
initiate the pancreatic gene program. Ventral foregut explants were found to initiate liver gene 
expression, if exposed to cardiogenic mesoderm or FGFs, or initiate pancreatic gene expression in the 
absence of such effectors. The ventral endoderm explant studies therefore indicate that the pancreatic 
program is the default state for this domain of endoderm. c. After the hepatic endoderm has been 
specified, it begins to extend towards the midgut. This process is abetted by turning of the embryo from 
the ‘gut out’ position to the inward curve shown by the typical fetus. At the same time, the hepatic 
endoderm cells become columnar in shape. These transitions seem to be elicited by signals that specify 
the endoderm. Cells such as septum transversum mesenchyme (STM) cells and primitive endothelial 
cells, signaling molecules (such as Bmp, HGF and Vegfr2) and transcription factors (such as Hex, 
Prox1, Hlx and c-Met) are essential to promote the morphogenesis of the liver bud itself (see d). d. 
Liver-bud morphogenesis is marked by the formation of the rostral diverticulum of the gut, remodeling 
of the extracellular matrix around the hepatoblasts and of E-cadherin-based connections between the 
cells, and proliferation and migration into the surrounding STM (beige). So, the hepatic endoderm 
(green) makes a transition from an epithelium to a non-polarized cell type during this period. Primitive 
endothelial cells, or angioblasts, appear near the hepatoblasts (c) and also promote outgrowth of the 
latter into the STM. During the outgrowth, the endothelial cells coalesce around spaces in the loose 
STM and create vesicles that fuse to form blood vessels (not shown). Haematopoietic cells then invade 
the growing liver and the organ becomes distinct from the gut epithelium. BMP bone morphogenetic 
protein; c-Met, HGF receptor; HGF, hepatocyte growth factor; Vegfr2, vascular endothelial growth 
factor receptor 2. Taken from Zaret. KS, 2002 
  14
demonstrate that although prox1 may be dispensable for hepatic specification, it is 
required for hepatoblast migration and the morphogenic expansion of the liver 
primordium (Sosa-Pineda et al., 2000). 
1.3.2.2.4 HNF family factors  
In addition to HNF3 (Foxa) factors mentioned earlier, three other HNF factors, 
HNF4α, HNF1 and HNF6 are also essential for hepatocyte differentiation.  
HNF4α is a transcription factor from the nuclear hormone receptor family which 
was firstly isolated by purification from liver nuclei (Sladek et al., 1990). It is 
expressed in the hepatic diverticulum at the onset of liver development (Duncan et al., 
1994). HNF4α-/- mouse embryos die before gastrulation due to the defects in visceral 
endoderm function (Chen et al., 1994). Studies using rat/human fibroblast hybrid cell 
lines and somatic hepatica cells variants that had de-differentiation found that HNF4α 
acted as an important regulator of hepatocyte differentiation (Bulla, 1997; Bulla and 
Fournier, 1994). Studies using E 11.5 fetal livers from HNF4α+/+, HNF4α+/-, HNF4α-/- 
ES cells by tetraploid aggregation, and also comparison of steady-state mRNA level 
of several characteristic hepatocyte marker genes in these livers by RT-PCR showed 
that loss of HNF4α function has an extreme and dramatic effect on hepatocyte gene 
expression. In all HNF4α-/- fetal livers examined, the expression of a large array of 
genes associated with mature hepatocyte function was virtually abolished (Li et al., 
2000). These findings show that HNF4α is essential for the expression of gene that 
defines a fully differentiated hepatocyte phenotype. Based on these results, HNF4α is 
proposed to be a hepatocyte differentiation factor and is crucial for normal 
development and functions of the liver. 
HNF6 belongs to the one-cut homeodomain transcription factor family. It is 
expressed in the early liver, the hepatic bile ducts and the gall bladder (Landry et al., 
1997; Rausa et al., 1997). In homozygous HNF6-null mutants, the gall bladder is 
absent and the hepatic bile ducts are not well refined (Clotman et al., 2002). In 
addition, at E 13.5 there seem to be more cells that express early biliary markers, 
which indicate excess biliary commitment from hepatoblasts. Therefore, HNF6 seems 
to restrict the extent of biliary-cell commitment as well as control the morphogenesis 
of the biliary ducts.   
HNF1b belongs to a homeodomain transcription factor and also known as 
transcription factor 2 (TCF2). The HNF1b mutant embryos show early dysplasia of 
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large intrahepatic bile ducts and the gall-bladder epithelium (Coffinier et al., 2002). 
The abnormal bile-duct epithelium in the liver of mutant HNF1b embryos, coupled 
with the expression of HNF1b in pancreatic exocrine ducts and kidney tubules in 
normal embryos, indicates that the transcription factor might generally control the 
development of epithelial tubules during organogenesis (Coffinier et al., 2002).  
 
1.4  Zebrafish as a model to study liver organogenesis 
1.4.1  The advantages of using zebrafish as a liver model  
Previous works in chick, mouse and rat model have brought us a lot of insights 
into the liver organogenesis. To reveal the detailed mechanism of liver development, a 
practical approach is to use forward genetic screening method to identify genes 
essentially involved in this process and then study their functions. However, the 
innate drawbacks of those models restricted them from being used in this method. 
Take mouse for an example, although it is a powerful reverse genetic tool, its 
relatively large size and low fecundity make it difficult to be used in performing 
forward genetic screening. The intrauterine development of mouse fetus is 
inconvenient for the observation of phenotypes in embryonic stages. In addition, liver 
is the initial site of hematopoiesis in mammals, thus liver defects in mouse often cause 
early embryonic death.  
Zebrafish has been revealed to be a vertebrate model organism that is suitable for 
forward genetic research. Its small size (3-4 cm long as adult) makes it easily be 
maintained in large quantities in laboratory environment. Its external development of 
transparent embryo allows fundamental vertebrate developmental processes, from 
gastrulation to organogenesis, to be visualized and studied under a microscope. Its 
short generation time (3-4 months) and high fecundity (females lay about 100-200 
eggs each time) facilitate large-scale genetic screening. In addition, mutations can be 
induced into zebrafish genome at high efficiency by chemical or insertional 
mutagenesis approaches (Patton and Zon, 2001). The mutant phenotype can be 
recovered within two generations and methods to discover the mutated genes, such as 
candidate gene approach and positional cloning method have been developed. More 
importantly, hematopoiesis in zebrafish takes place in the intermediate cell mass 
(ICM) and subsequently in the kidney, not in the liver, thus liver defect does not lead 
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to embryonic lethal for anemia (Thisse and Zon, 2002). All these advantages make the 
zebrafish an excellent model for forward genetic studies of liver organogenesis.  
   
1.4.2 Study of liver development in zebrafish 
Study of liver development in zebrafish has a relatively short history. Currently 
the morphology of zebrafish liver organogenesis has been well described, especially 
in a study by Field et al with the help of the Tg (gutGFP) S584 transgenic fish (Figure 
1-5). In addition, a few zebrafish genes related to liver development have been 
identified in genetic screening. 
 
1.4.2.1  Liver organogenesis in zebrafish 
Liver is an endoderm derived organ. Although the situation of endoderm 
morphogenesis is different in zebrafish and other species(Zorn and Wells, 2007), the 
molecular pathways controlling hepatogenesis appear to be conserved in 
vertebrates(Stainier, 2002). In zebrafish, the specification of liver is marked by the 
localized endodermal expression of hex and prox1 at 22 hours post fertilization (hpf). 
At 24 hpf, the definitive endoderm appears as a solid rod along the midline cells just 
above the yolk cells, called the intestinal rod. The rod is just rostral to the first somite. 
By 28 hpf, two thickened regions already emerged on the intestinal rod. The anterior 
one, which positioned slightly left of the midline and projects from the ventral side of 
the rod under the first somite, will give rise to the liver bud while the posterior one 
will contribute to the pancreas (Field et al., 2003; Wallace and Pack, 2003). Studies in 
mouse and chick suggest that the differentiation of ventral foregut cells into 
hepatoblasts requires BMP and FGF signaling molecules from adjacent cardiac 
mesoderm and septum transversum mesenchyme (Zaret, 2000). The similar 
mechanism has been demonstrated in zebrafish just recently by overexpressing of 
dominant-negative forms of BMP and FGF receptors upon heat-shock induction (Shin 
et al., 2007). In addition to these two mesodermal signals, Prt / Wnt2bb signaling 
molecules from adjacent bilateral mesoderm was also reported to be essential in liver 
specification in zebrafish (Ober et al., 2006). prox1 gene expression could be detected 
at the hepatic bud at this stage (Ober et al., 2003), suggesting that, as observed in 
mouse, prox1 is probably required in the migration of hepatoblasts into the 
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surrounding mesenchyme (Sosa-Pineda et al., 2000). hex, another gene essential for 
mouse hepatic specification, is also expressed in hepatoblasts at this stage, which is 
similar to that observed in mouse. Knockdown of hex via morpholino injection led to 
a largely reduced liver size by 50 hpf, indicating that hex is essential for liver 
development in zebrafish (Wallace et al., 2001). Retinoid acid (RA) has also been 
shown to be necessary for the specification of hepatoblasts in zebrafish (Stafford and 
Prince, 2002) 
At 30 hpf, the zebrafish hepatoblasts continue to aggregate, which lead to the 
thickening of the endoderm rod between esophagus and intestinal bulb (stomach). 
Meanwhile, the thickened endoderm rod along the midline bends to the left side, 
accompanied by a left looping of the intestinal rod. This gut-looping process is 
mediated by the asymmetric migration of the left and right LPM sheets that generates 
a motive force to drive the migration of the anterior portion of the digestive system 
(Horne-Badovinac et al., 2003). A discrete liver is formed by 34 hpf, after which time, 
the liver undergoes budding and growth two phases (Ober et al., 2003; Wallace and 
Pack, 2003; Field et al., 2003). During growth stage, the nascent liver bud increases 
significantly in size, results in a smooth, thickened area along the outer curvature of 
the intestinal bulb primordium. Then furrow starts to form between the liver bud and 
the adjacent esophagus and expands posteriorly, restricting the connection between 
the liver and the intestinal bulb primordium. Cells connect these two organs will 
finally form the hepatic duct at around 50 hpf (Field et al., 2003). Liver 
vascularization starts just after the completion of budding phase (Ober et al., 2003). 
Initially at around 60 hpf, the endothelial cells partially encapsulate the liver bud start 
to invade inwards the liver bud and commence the liver vascularization. This is a very 
rapid process and the whole liver is vascularized by 72 hpf (Field et al., 2003). The 
development of the bile duct cells is concurrent with the liver vascularization. 
However, bile ducts development is independent of liver vascularization (Lorent et al., 
2004) and sensitive to hnf6-mediated gene transcription (Matthews et al., 2004). 
Liver vascularization is coupled by rapid growth (Figure 1-6). By 72 hpf, the size 
of the liver has increased moderately as compared with that in 50 hpf, but the overall 
shape has not altered. By 96 hpf, the liver growth has resulted in a medial expansion 
so that it extends from the left side of the embryo all the way cross the midline ventral 
to the esophagus. As a result, the liver comes to occupy a substantial portion of the 
abdominal cavity and spreads across the midline. At 5 dpf, the two lobes of the liver 
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forms and the liver become fully functional. Through genetic studies, seven genes 
have been identified as negative regulators (Sadler et al., 2005) while a novel 
pan-endoderm gene def and an RNA-binding protein gene nil per os (npo) were 
identified as positive regulators (Chen et al., 2005; Mayer and Fishman, 2003) for 
liver expansion growth in zebrafish. It has been reported that pescadillo (pes) gene 
(Allende et al., 1996) and hex (Wallace et al., 2001) are essential in this process of 
rapid growth. Zebrafish pes mutant appears normal at 3 dpf but displays a lack of 
expansion of the liver and gut when checked at 5 dpf, indicating a sudden arrest in 
organ growth between 3 and 5 dpf (Allende et al., 1996). Hex Knocking-down by of 
antisense morpholino injection leads to strong reduction of liver size and also 




Figure 1-5. Time course of liver budding in zebrafish. (A–F) Two-dimensional projections of 
confocal stacks showing ventral views of the gutGFP line, anterior to the top. Scale bar, 100 _m. 
Embryos were fixed and imaged at (A) 24, (B) 28, (C) 30, (D) 34, (E) 36, and (F) 46 hpf. (A, B) The 
liver (arrowhead) starts budding from the intestinal rod between 24 and 28 hpf. (C) At 30 hpf, the liver 
is a smooth thickening on the outer curvature of the intestinal bulb primordium, which at this time has a 
clear leftward bend. (D) A furrow (open arrow) begins to form between the medial anterior edge of the 
liver and the adjacent esophagus and continues to expand posteriorly (E, F) to separate the liver from 
the intestinal bulb primordium. The pancreas (asterisk) and endodermal lining of the swim bladder 
(arrow) can also be seen developing from the intestinal bulb primordium over time. (G–I) Transverse 
sections through the gutGFP line stained with rhodamine-labeled phalloidin to visualize surrounding 
tissues. The liver is marked by an arrowhead; the intestinal bulb primordium is outlined in white. 
Dorsal is to the top, and left is to the right to keep with the orientation of the ventral views. The level of 
the sections in (G–I) is indicated by the yellow dashed lines in (B), (C), and (E), respectively. (G) At 28 
hpf, the first aggregation of hepatocytes from the intestinal bulb primordium is slightly to the left of the 
midline and adjacent to the yolk (y). The tissue that resides between the endoderm and the overlying 
notochord and somites is the lateral plate mesoderm. (H) At 30 hpf, the budding liver, which is 
positioned left of the midline, has an extensive connection to the intestinal bulb primordium. Lateral 
plate mesoderm is present both dorsal and ventral to the intestinal bulb primordium, but not ventral to 
the liver. (I) By 36 hpf, the connection between the liver and intestinal bulb primordium has started to 
restrict, and lateral plate mesoderm is present in the resulting space. The liver sits directly on the yolk 












Figure 1-6. Liver growth in zebrafish. Compare with the budding stage, liver growth is 
characterized by rapid size increase and morphologic change. At 3 dpf, the liver size is increased 
dramatically when compared with that at 48 hpf, and the liver sits on the left side of the midline. At 4 
dpf, the liver is seen to generate a second lobe which is extending to the right side of the midline. At 5 
dpf, the two lobes of the liver become obvious. Liver specific marker lfabp probe was used in whole 
mount in situ hybridization to generate these images. 
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1.4.2.2  Study liver development through genetic approaches in 
zebrafish 
Owing to its advantages as a forward genetic model, several genetic screens have 
been carried out in the zebrafish system and gave rise to a number of mutants with 
liver defects. Some of the mutants are related to genes which are known to be 
essential for liver organogenesis, such as the gata5 mutant discovered in a large scale 
ENU mutagenesis in 1996 (Chen et al., 1996). However, most of these liver defects 
are caused by mutations in unknown genes such as pes (Allende et al., 1996) and nil 
per os (npo) (Mayer and Fishman, 2003). In addition, study in a few of the liver 
mutants revealed the involvement of pathways which are previously unexpected to 
affect organogenesis. For example, the def mutation was found to repress the 
expansion growth of liver as well as pancreas and intestine via upregulation of 
Δ113p53, an isoform of the well known tumor suppressor p53 (Chen et al, 2005). 
Furthermore, several zebrafish mutants exhibited traits that could be used for disease 
model. For example, the class C vacuolar protein sorting gene vps18 mutant has large, 
vesicle-filled hepatocytes and defects in the bile canaliculi. These phenotypes 
resemble the human arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome, 
which is the result of a mutation in another class C vps gene. The tumor suppressor 
gene nf2 mutant develops extrahepatic choledochal cysts in the common bile duct, 
suggesting that this gene regulates division of biliary cells during development and 
that nf2 may play a role in the hyperplastic tendencies observed in biliary cells in 
individuals with choledochal cysts. The mutant of a novel gene, foie gras, develops 
large, lipid-filled hepatocytes, resembling those in individuals with fatty liver disease 
(Sadler et al., 2005).  
The discoveries and studies of these mutants are good demonstration of the 
potential of using zebrafish as a genetic model to study liver development and disease.  
1.5  The study of COPII complex 
1.5.1 . The COPII complex is essential for protein transport from ER to 
Golgi 
In eukaryotes, newly synthesized secreted proteins need to be properly 
transported from one membrane compartment to another for cell growth and 
maintenance. This kind of transportation is mediated by vesicular vectors, which are 
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composed by delicately regulated assembly of coat protein complexes (COPs) on 
donor organelles. The COPs form a shell and also turn a portion of the donor 
membrane into a transport vesicle in which cargo proteins are loaded. The transport 
vesicle containing cargos moves to the receptor organelle, in which the cargos are 
released and coat proteins are recycled. There are several kinds of COPs that have 
been discovered, such as the Clathrin complex that mediates the endocytosis on the 
plasma membrane, the COPI complex that involves in retrograde transport within the 
Golgi and from the Golgi back to ER, and the COPII complex which is responsible 
for transport of newly synthesized cargos from ER membrane to Golgi apparatus 
(Figure 1-7) (Lodish et al., 1999).  
COPII complex and its component proteins were initially discovered in yeast (S. 
cerevisiae) by genetic analysis of secretion mutants which have defects in ER to 
Golgi transport (Letts and Dawes, 1983; Oka et al., 1991). Structural, morphological, 
genetic and molecular studies later revealed that COPII complex is evolutionally 
conserved, both in its composition and function, in eukaryotes. The ER membrane 
makes up the largest portion of total membrane in the cell. It was estimated that in 
yeast, approximately one-third of total proteins are delivered to other organelles or the 
cell surface via ER membrane (Ghaemmaghami et al., 2003; Huh et al., 2003). 
Since protein export by COPII vesicle is the default ER-to-Golgi route which has 
been revealed in yeast and mammal cells, the COPII vesicle must be capable of 
accommodating a variety of cargo proteins with different structures, functions and 
destinations. Numerous works, including a variety of reconstituted in vitro assays as 
well as high-resolution structural analysis, have been conducted to reveal the 







Figure 1-7. Intracellular vesicular traffic and transport vesicles. Schematic representation of 
organelles and protein transport routes in the secretory pathways. Transport vesicles (50–100 nm in 
diameter) are generated by the actions of both coat proteins and small GTPases. The vesicle formation 
is initiated by the recruitment of cytoplasmic coat proteins to the surface of the donor membrane, which 
then induce deformation of the membrane into a coated vesicle. The COPII coat is known to mediate 
export from the ER to either the ER–Golgi intermediate compartment (ERGIC) or the Golgi complex. 




1.5.2 The recruitment and assembly of COPII transport vesicle 
1.5.2.1  Assembly of core COPII components 
The recruitment and assembly of COPII complex has been studied in detail in yeast 
and in mammalian cells. COPII complex is composed by five core cytosolic protein 
components, the small GTPase Sar1, the Sec13/Sec31 heterotetramer and the 
Sec23/Sec24 heterodimer (Barlowe et al., 1994) (Figure 1-8). Sar1 activation from 
GDP to GTP bounded form by Sec12, a guanine-nucleotide exchange factor (GEF) 
resides in ER membrane, is the first step of COPII complex biogenesis (Nakano et al., 
1988; Nakano and Muramatsu, 1989; Barlowe and Schekman, 1993). Sar1-GTP 
undergoes conformational change upon activation. Its hydrophobic N-terminal 
exposes and inserts into the ER membrane, serves as an anchor for the rest of the 
assembly events (Huang et al., 2001). Membrane bounded Sar1 recruits the 
Sec23/Sec24 complex through its carboxyl-terminal region interaction with Sec23 (Bi 
et al., 2002). Altogether, they enrich cargo proteins and deform the membrane into 
tubule like pre-budding-complex, which is usually refereed to as ERES (ER exit site) 
(Kuehn et al., 1998). The subsequent recruitment of Sec13/Sec31 complex onto ERES 
via physical interaction between Sec23 and Sec31 clusters the pre-budding-complexes 
into COPII transport vesicles (Lederkremer et al., 2001). The final fission of the 
COPII vesicle from ER membrane is triggered by Sar1-GTP hydrolysis mediated by 
Sec23, which serves as a Sar1 specific GTPase activator (Bielli et al., 2005; Lee et al., 
2005b; Antonny, 2006). 
Beside these five core components, two other proteins are also shown to be 
involved in the assembly of COPII complex. Sec16 is a large ER-resided 
multi-domain protein (Espenshade et al., 1995). In vivo studies in yeast and 
mammalian cells indicated that it functions as a scaffold to tether Sec23, Sec24 as 
well as Sec31 and therefore enhances the efficiency of COPII budding. Another 
integral ER membrane protein Sed4 was first isolated as a dosage-dependent 
suppressor of yeast temperature-sensitive sec16 mutations (Gimeno et al., 1995). 
Recently it was characterized to function as a positive regulator of Sar1. Although 
Sed4 is homologous to Sec12, they are not functionally related (Saito-Nakano and 
Nakano, 2000). Sed4 deletion in yeast is not lethal. Its absence only decreases the ER 
to Golgi transport efficiency and exacerbates mutations defective in vesicle formation, 










Figure 1-8. COPII vesicle formation and the selective uptake of cargo proteins. The COPII 
vesicle formation is initiated by GDP–GTP exchange on Sar1 catalyzed by the transmembrane guanine 
nucleotide exchange factor Sec12. Activated Sar1-GTP binds to the ER membrane and recruits the 
Sec23/24 subcomplex. The cytoplasmically exposed signal of transmembrane cargo is captured by 
direct contact with Sec24, forming the ‘‘prebudding complex’’. It is currently not clear whether the 
membrane-bound Sar1-GTP associates with cargo before the recruitment of Sec23/24 or lateral 
diffusion of Sar1-GTP-Sec23/24 complex captures cargo. These prebudding complexes are clustered 







1.5.2.2 Transport cargo selection and sorting 
The most of membrane and soluble cargo proteins are sorted into COPII vesicles 
to transport from ER. This process of selective capture is basically driven by export 
signals within the amino acid sequence of each cargo protein contained on their 
cytoplasmically exposed regions (Barlowe, 2003). Export signals of most 
transmembrane cargo proteins are thought to interact directly with the COPII coat 
subunits, but some transmembrane and most soluble cargo proteins bind indirectly to 
COPII through transmembrane cargo adaptors/receptors, offering a mechanistic 
explanation for their specific capture into COPII vesicles. A combination of structural, 
biochemical, and genetic approaches have revealed that these divergent signals are 
recognized by distinct cargo binding sites on the Sec24 subunit of the Sec23/Sec24 
complex (Mossessova et al., 2003; Miller et al., 2003). The existence of various 
subtypes of Sec24 expands the cargo multiplicity captured by COPII coat (Jung et al., 
1999; Roberg et al., 1999; Pagano et al., 1999). In addition, recent studies have 
suggested that Sar1 also plays a role in cargo recognition by direct binding to the 
export signals (Giraudo and Maccioni, 2003). 
In addition to the COPII mediated ER transport, some proteins are shown to exit 
the ER via a nonspecific process known as ‘‘bulk-flow’’. However, this approach 
appears to be apparently inadequate and contributes in a relatively minor way to 
protein secretion (Malkus et al., 2002). 
 
1.5.3 The structure of COPII coat 
Numerous efforts have been made to reveal the three-dimensional structure of the 
COPII complex, which could probably help to explain its ability to accommodate a 
variety of cargos (Figure 1-9). Early electron microscopy study on purified yeast 
COPII complex indicated its cage-like structure (Salama et al., 1993). The similar 
results was obtained in a study in which COPII vesicles is reconstructed in vitro with 
isolated yeast microsomes, purified coat proteins and a ATP regeneration system 
(Lederkremer et al., 2001). Later, the cage-like structure of COPII complex was 
successfully reconstituted in vitro with coat proteins only and in absence of the 
liposome, which suggested a COPII assembly model that the membrane deformation 







Figure 1-9. The cage-like COPII complex. A. Purified yeast COPII complex, taken from Salama 
et al., 1993. B. COPII cage in vitro constituted with purified proteins and artificial liposome, taken 
from Lederkremer et al., 2001. C. COPII cage in vitro constituted without liposome, taken from 
Antonny et al., 2003. 
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 Last year, Stagg et al demonstrated that the minimal COPII cage could be formed by 
the self-assembling of Sec13/Sec31 heterotetramer in vitro (Stagg et al., 2006). In 
contrast to a previous model, they proposed that Sec23/Sec24 complex has 
non-structural role as a multivalent ligand localizing the self-assembly of 
Sec13/Sec31 to form a cage lattice driving ER cargo export. Furthermore, they 
presented a three-dimensional reconstruction of the minimal COPII cages at 30 Å 
resolution using cryo-electron microscopy and single particle analysis. Their results 
revealed the novel cuboctahedron geometry of the COPII complex, as well as the 
structure model of its basic assembly unit. They also indicated that the COPII cage 
has a potential to form a flexible lattice to generate a diverse range of containers 
(Figure 1-10).  
Just recently, the organization of coat proteins in the COPII complex was 
uncovered by Fath et al via crystallographic analysis of the basic assembly units (Fath 
et al., 2007). Their study presented a new model of the COPII cage which is 
consistent with the one described before by Stagg et al, and with more detail. Their 
results resolved the previous controversialism over the positioning of Sec13 and 
Sec31 on the basic assembly unit (Stagg et al., 2006). They also proposed that the 
basic assembly unit has a central hinge which can bend to adapt to cages of variable 
curvature (Figure 1-11), which would be essential for the accommodation of a variety 
















Figure 1-10. 30A° resolution map of the Sec13/Sec31 cage. a, Views of a typical cage along its 
two-fold (left panel), three-fold (centre panel) and four-fold (right panel) axes of symmetry. The 
surface of the cage is colored from blue (nearest) to yellow (farthest) according to its distance from the 
centre of the volume. Scale bar, 500A °. b, The asymmetric unit and vertex of the cuboctahedral 
Sec13/31 lattice. Structural features are numbered 1–6. The proposed Sec13/31 heterotetramer 
arrangement is indicated by the green lines for Sec13 and blue lines for Sec31. c, Close-up of a cage 
vertex. Vertex– vertex (v–v) and edge–vertex (e–v) interactions are indicated. d Possible cage 














Figure 1-11. Organization of the assembly unit in the COPII cage. A. Comparison of the 
molecular model of the Sec13/31 assembly unit with the asymmetric unit of the cryo-EM map of the 
mammalian COPII cage (Stagg et al., 2006). The objects are viewed along the local 2-fold rotation axis. 
The model, shown in space-filling representation, is a composite of the two crystal structures. The 
arrows indicate the _15A° displacement of the Sec13 b-propellers from the axis of the a-solenoid rod 
and the corresponding features in the cryo-EM map. B. Orthogonal view shows the difference in the 
angle at the center of the assembly unit. Here, the arrows show the 15–20A° displacement of the Sec31 
b-propellers from the a-solenoid axis. C. The molecular model of the heterotetrameric assembly unit 
was separated into two Sec13/31 heterodimers, and these were fitted independently as rigid bodies into 
the cryo-EM map (see Experimental Procedures). The picture shows a complete vertex (two 
asymmetric units of the cage) and is viewed along the 2-fold symmetry axis that runs through the 
vertex. One symmetry-related pair (colored dark green and orange) converges at the vertex and is 
labeled proximal; the other symmetry-related pair (light green and red) is labeled distal. D. The 
molecular model of the cage comprises 24 copies of the assembly unit with octahedral or 432 
symmetry. Superimposed is the 30A ° cryo-EM density map from Stagg et al. (2006). Taken from 
Stephan et al., 2007 
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1.5.4 Study of COPII complex in whole organism level 
Traditional studies of COPII complex were carried out in yeast and mammalian 
cells. Although the homologues of all COPII components have been found in 
vertebrates and plants, their implications were rarely investigated in whole organism 
level.  
Just last year, two articles reported the study of a sec23a mutation in human and 
zebrafish. In the first study, positional cloning work revealed that an F382L amino 
acid substitution in SEC23A segregates with human Cranio-lenticulo-sutural dysplasia 
(CLSD) disease, an autosomal recessive syndrome characterized by late-closing 
fontanels, sutural cataracts, facial dysmorphisms and skeletal defects. Electron 
microscopy in fibroblasts from individuals with CLSD syndrome revealed gross 
dilatation of the ER. In addition, these mutant cells also exhibit mislocalization of 
Sec31 as revealed by immunofluorescence. In vitro reconstitution experiment 
demonstrated that F382L is a loss-of-function mutation. A phenotype relevant to 
CLSD is observed in zebrafish sec23a morphants (Boyadjiev et al., 2006). These 
findings were concerted by the results in the second study, in which the zebrafish 
sec23a L402X mutant (crusher) exhibits a phenotype comparable to CLSD. crusher 
mutants appear normal until the onset of craniofacial chondrogenesis. Mechanism 
study revealed that crusher chondrocytes accumulate proteins in a bloated ER, 
resulting in severe reduction of cartilage extracellular matrix (ECM) deposits. So far 
the zebrafish crusher mutant is the first vertebrate model system that links COPII 
mediated protein transportation with a clinically relevant human syndrome (Lang et 
al., 2006). 
 
1.6  Rational and aim of the project 
The liver is the largest internal organ in human body and plays many essential 
functions. Although a lot of work has been done to study its roles in metabolism and 
maintaining homeostasis, liver initiation and development are currently poorly studied 
and only a handful of information has been obtained from tissue explantation and in 
vitro tissue culture methods. To reveal the myth of liver organogenesis, a practical 
approach is to use forward genetic screening to find out essential genes involved in 
  32
this process and then study their working mechanisms. However, previous liver 
models, such as chick, mouse and rat, are not suitable for large scale mutagenesis and 
screening. Zebrafish has already been known as a good forward genetic model system 
to study embryogenesis. Even though its unique advantages in the study of liver 
organogenesis have been well characterized, no previous genetic screening in 
zebrafish was aimed specifically in liver mutants.  
The purpose of this project is to study liver development in zebrafish system via 
forward genetic approaches. Preliminarily, 57 putative zebrafish mutants with no-liver 
or small-liver phenotype were obtained from a moderate scaled ENU mutagenesis and 
genetic screening in our group, which was initiated in 2001. Outcross will be 
performed on those lines for maintenance as well as for genetic background 
purification. For the confirmed mutants, positional cloning approach will be used to 
identify the mutation sites. The mechanism of these mutations will finally be 
deciphered via molecular, cellular, genetic and genomic methods. The mutant 
collection in our group would be invaluable resources to study liver organogenesis. 
Since endoderm development seems to be conserved in vertebrates, the new findings 
about liver embryogenesis in zebrafish would be meaningful in other vertebrates and 
even mammals, such as mouse or human. 
As the initial stage of the project, this study will focused on the positional cloning 
work and mechanism study of one selected mutant, sec13sq198, while the rest will be 
maintained and to be worked on in the future. Our study will not be restricted to the 
zebrafish system only. At certain stages of the project, especially after the positional 
cloning work, we will seriously consider taking the advantages of zebrafish and other 
systems, such as yeast and human cell line to facilitate our biochemical studies. The 
details of the experiments of this study will be presented in the following chapters.  
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Chapter 2. General Materials and Methods  
2.1  Fish lines and maintenance conditions 
The zebrafish (Danio rerio) lines used in this study were wild-type AB line，the 
wild-type WIK line，and the transgenic Tg(lfabp:rfp;elaA:gfp) line (Her et al., 2003; 
Wan et al., 2006). 
Zebrafish were raised essentially as previously described (Westerfield, 1995). 
Embryos were obtained by natural spawning and then cultured in egg water (E3 
medium) at 28.5℃ till 5 day post fertilization (dpf). The embryo staging is presented 
in hours post fertilization (hpf) or days post fertilization (dpf) as previously described 
(Kimmel et al., 1995). Embryos for in situ hybridization, alkaline phosphatase 
staining and alcian blue staining analyses were treated with 0.003% 
1-phenyl-2-thiourea（1X PTU）between 12 hours post fertilization (hpf) and 24 hours 
post fertilization to inhibit melanin pigment formation.  
2.2  Chemical solutions and growth medium  
 
Name Formular 
Egg Water (E3 medium) 
5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and 
0.33 mM MgSO4. To suppress growth of mold, 
the medium was supplemented with 0.03mM 
methylene blue. 
50X PTU 
1.5 g 1-phenyl-2-thiourea (Sigma, Cat. No. 
P7629) dissolve in 1liter double distilled water. 
The final concentration is 0.15%. 
Blocking Buffer for in-situ 
hybridization 
10 % (V/V) Bovine Calf Serum (Hyclone Cat. 
No. SH30073.03) diluted in PBST. 
Hybridization buffer 
(Hyb+)for in-situ hybridization 
(1L) 
Formamide 500ml, 20 x SSC 250ml, 1M citric 
acid (pH6.0) 0.92 ml, 0.1 % Tween20 (V/V), 50 
μg/ml Heparin (Sigma Cat. No.H-3400), 1mg/ml 
tRNA (Sigma Cat. No. R-6750), top up with 
DEPC treated H2O to 1L. 
Detection buffer for 
NBT/BCIP 
100 mM Tris HCl pH 9.5, 50 mM MgCl2, 100 
mM NaCl, 0.1% Tween 20 (V/V). 
NBT/BCIP staining solution 
1 tablet from Sigma (Cat. No. B5655) dissolved in 
10 ml H2O, which containing nitro blue 
tetrazolium chloride (NBT), 0.30mg/ml, 
5-bromo-4-chloro-3-indolyl phosphate (BCIP), 
0.15mg/ml. Supplement with 0.1% Tween 20 
(V/V) before use. 
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Detection buffer for Fast Red 100mM pH 8.2 Tris, 0.1% Tween 20 (V/V). 
Fast Red staining solution 
1 tablet Fast Red (Roche Cat. No.1 496 549) 
dissolved in 2 ml 0.1 M pH 8.2 Tris, 0.1% Tween 
20 (V/V). 
LB medium 1% (W/V) Bacto-tryptone, 0.5% (W/V) yeast extract, 1 mM NaCl, pH 7.0. 
MOPS/EDTA (10X) 50 mM NaOAC, 0.2M MOPS pH 7.0, 10 mM EDTA, filter, store in dark at RT, pH 7.0. 
RNA Sample Buffer 
10ml deionized formamide, 3.5 ml 37% 
formaldehyde, 2 ml 10X MOPS. Dispense into 
single use aliquots and store in -20  in tightly ℃
sealed capped tubes. These can be stored for up to 
6 months. 
RNA Loading Buffer 
50% glycerol, 1mM EDTA, 0.4% bromophenol 
blue. Prepare in DEPC-treated or Nuclease-Free 
Water. Use high-grade glycerol to avoid 
ribonuclease activity. Dispense into single-use 
aliquots and store at -20 .℃  
PBS (10X) 
80 g NaCl, 2 g KCl, 11.5g Na2HPO4, 2 g 
KH2PO4 in 1 liter H2O, the final concentration is 
1.137M NaCl，27mM KCl，81mM Na2HPO4，
15mM KH2PO4. 
PBST 1 x PBS with 0.1% Tween 20 (V/V). 
Phenol Red 0.5% (Sigma Cat. No. P-0290) (W/V). 
Embryo fixate [4% PFA 
(W/V)] 
40g paraformaldehyde (Sigma P6148) in 1L 
PBST, dissolve in 65 , cool down on ice and ℃
stored at 4 .℃  
SOB medium 
2 % (W/V) Bacto-tryptone, 0.5 % (W/V) yeast 
extract, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4, pH 6.8-7.8 
20X SSC 
175.32g Sodium Chloride, 88.23g Sodium Citrate, 
dissolve in 800ml water, adjust to pH 7.0 with a 
few drops of HCl, top up with water to 1L and 
autoclave. The final concentration is 3 M NaCl, 
0.3 M Sodium Citrate. 
50X TAE 
242 g Tris-base, 57.1 ml Glacial Acetic Acid, 
100ml 0.5M EDTA, adjust to pH 8.2 with HCl, 
top up with sterile water to 1L. The final 
concentration is 2M Tris, 1M Acetic Acid, 50 mM 
EDTA. 
10X TBE 
108.8g Tris-base, 55g boric acid, 40ml 0.5M 
EDTA, top up with water to 1L and autoclave. 
The final concentration is 890mM Tris-base, 
890mM boric acid, 20mM EDTA. 
TB buffer 
10 mM Hepes (or Pipes) 15 mM CaCl2, 250 mM 
KCl. pH was adjusted to 6.7 with 1M KOH. 
Dissolve MnCl2 (final concentration at 55 mM) in 
TB buffer. Sterilize the solution by filtration 
through 0.45 μm filter and store at 4℃ 
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TE 10mM Tris-HCl, 1mM EDTA, pH8.0 
PCR reaction buffer (10X) 
3.728g KCl, 10ml 1M Tris-HCl (pH 9.0), 0.143g 
MgCl2, 1ml Triton® X-100 (BioRad, Cat. No. 
161-0407), top up with double distilled water to 
100ml and autoclave. The final concentration is 
0.5M KCL, 0.1M Tris-HCl, 15mM MgCl2, 1% 
Triton X-100. 
Mammalian cell lysis buffer 
23 mM Hepes (pH 7.3), 0.15 mM NaCl, 1.5 mM 
MgCl2, 0.2 mM EDTA, 5% Glycerol, 0.25% 
Triton X-100, supplement with protease inhibitor 
(Roche, Cat. No. 1873580) prior to use. 
SDS sample buffer 
0.63 ml 1M Tris-HCl, pH 6.8, 1 ml glycerol, 0.5 
ml β-mercaptoethanol, 1.75 ml 20% SDS, 6.12 ml 
H2O. The final concentration is 63 mM Tris-HCl, 
10% Glycerol, 5% β-mercaptoethanol, 3.5% SDS.
Zebrafish embryo lysis buffer
10 mM Tris-HCl (pH 8.2), 50 mM KCl, 0.3% 
Tween-20, 0.3% NP-40, add 1/40 volume 
Proteinase K (FINNZYMES, Cat. No. F-202L) 
prior to use. 
Adult zebrafish lysis buffer 
100 mM Tris-HCl (pH 8-8.5), 200 mM NaCl. 
0.2% SDS, 5 mM EDTA, supplement with 1/200 
volume Proteinase K (FINNZYMES, Cat. No. 
F-202L) prior to use. 
SDS-PAGE running buffer 
(10X) 
Tris base 30.3 g, Glycine 144 g, SDS 10 g, 
dissolve in 800 ml sterile water, adjust to pH 8.3 
with HCl and then top up with sterile water to 1 L. 
The final concentration is 250 mM Tris-HCl, 2 M 
Glycine, 1% SDS. 
SDS-PAGE transfer buffer 25 mM Tris-HCl (pH 8.3), 192 mM glycine, 20% MEOH 
Laemmli buffer (5X) 
1.5 g SDS, 3.75 ml 1M Tris-HCl (pH. 6.8), 
0.0015 g Bromphenol blue, 1.16 g DTT, 7.5 ml 
Glycerol, dissolve and top up with sterile water to 
15 ml. The final concentration is 10% SDS, 250 
mM Tris-HCl, 0.1 ‰ Bromphenol blue, 500 mM 









2.3 Molecular cloning procedures: 
2.3.1 . Polymerase chain reaction (PCR) 
The composition of a typical PCR reaction was prepared as described in Table 
2-1. Typical thermal cycler condition was listed in the Table 2-2 
 
Table 2-1. Typical reaction composition of PCR 
Component Volume per Final concentration 
10X PCR Buffer 2.5 μl 1 X 
dNTP (10 mM) 0.5 μl 200 μM each 
5’ Primer (10 mM) Variable 0.1-0.5 μM 
3’ Primer (10 mM) Variable 0.1-0.5 μM 
Taq DNA 0.2 μl ~ 1 units/reaction 
Template DNA <0.5 μg ___ 
Distilled Water Variable ___ 
Total Volume 25 μl ___ 
 
 
Table 2-2. Typical thermal cycler conditions of PCR 
Cycles Condition Comments 
1 X 94℃, 3 minutes Initial denaturation 
94℃, 30 seconds Denaturation 
48-62℃, 30 seconds 
Annealing, usually 5℃ below 
the predicated Tm of primers 30-40 X 
72℃, 1 minutes or more Extension, approximately 1 
minutes per kb DNA product 
1 X 72℃, 10 minutes Final extension 
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2.3.2 Purification of PCR product/DNA fragments from agarose gel 
PCR products or DNA fragments were fractionated and excised from 1% agarose 
gel under long UV light and further purified through High Pure PCR product 
purification kit (Roche, Cat. No. 11732668001) following the instructions of the 
manufacturer.  
 
2.3.3 Ligation of DNA insert into plasmid vectors 
2.3.3.1  Ligation using pGEM®-T /pGEM®-T Easy vector system 
Direct ligation of purified PCR fragment in to pGEM®-T /pGEM®-T Easy vector 
(Promega, Cat. No. A3600 and A1360) was performed essentially as described in the 
manufacture’s instructions.  
 
2.3.3.2  Insert DNA fragment into other plasmid vectors 
Plasmid vector and purified DNA fragments were digested with appropriate DNA 
restriction enzymes from New England Biolabs (NEB).  Dephosphorylation of 
linearized vector was performed by incubation with CIP (Calf Intestinal Alkaline 
Phosphatase, NEB, Cat. No. M0290S). After purification of the digested fragments 
with spin column (Roche, Cat. No. 11732668001), ligation reaction was performed by 
using rapid DNA ligation kit (Roche, Cat. No. 11 635 379 001) following the 
instructions from the manufacture. 
 
2.3.4 Transformation of bacterial with plasmid 
2.3.4.1  Preparation of DH5α E. coli competent cells 
A single colony of DH5α from a fresh streaked plate was used to inoculate in 250 
ml of SOB medium in a 2-liter flask and then incubate to an OD600=0.6 at 18℃ 
incubator with vigorous shaking (200-250 rpm), followed by incubation on ice for 10 
minutes. The cells were pelleted by spin at 2500 x g on Beckman J-6B centrifuge for 
10 min at 4℃ and then suspended in 80 ml of ice-cold TB medium and incubated on 
ice for another 10 minutes. The spin was repeated and this time the pellet was 
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re-suspended in 20 ml of TB with gentle swirling. After the re-suspension, DMSO 
was added to the mixture at a final concentration of 7% (V/V), followed by 10 
minutes incubation on ice. The cell suspension was dispensed in 50ul aliquots in PCR 
stripes and instant-frozen by immersion in liquid nitrogen. The frozen competent cells 
were kept in -80℃ freezer for long term storage. 
 
2.3.4.2  Plasmid transformation of E. coli cells via heat-shock 
method 
Prior to a transformation reaction, the frozen competent cells were thawed on ice 
for 10 minutes before being transferred into pre-chilled 1.5ml microcentrifuge tubes. 
Then appropriate volume of plasmid DNA (0.5~1μl) or ligation products (5ul from a 
standard 20ul ligation reaction) were added to each aliquot of competent cells and 
mixed by gentle finger flipping, followed by incubation on ice for 30 minutes. After 
the incubation, the cells were heat-shocked on 42℃ water bath for exactly 90 seconds 
and then incubated on ice for 10 minutes. The cells transformed with plasmid can be 
streaked or plated on LB plate (with appropriate antibiotics) directly at this stage. The 
cells transformed with ligation products were mixed with 750 μl LB medium (w/o 
antibiotics) and incubated at 37℃ for 30-45 minutes. Cells were pelleted by brief 
spinning before being plated onto a LB plate. The plates were incubated overnight at 
37℃ to allow the growth of colonies.  
 
2.3.4.3  Isolation of plasmid DNA from E. coli.  
A single bacterial colony from a transformed plate was picked to inoculate in 5 to 
15 ml of LB medium with appropriate antibiotics. The culture was incubated at 37℃ 
overnight with vigorous shaking (200-250 rpm). Mini-prep of plasmid DNA was 
conducted by using QIAGEN Plasmid Mini Kit (QIAGEN, Cat. No 12125) according 
to the manufacturer’s instruction.  
 
2.4  DNA sequencing  
DNA sequences of plasmid insertion or PCR product were determined using ABI 
BigDye® Terminator v3.1 (Applied Biosystems, P/N 4337458). The sequencing 
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reaction was composed as indicated in the Table 2-3. The thermal cycler condition 
was listed in the Table 2-4. The product purification and the final sequence 
determination were performed by the DNA sequencing lab in IMCB. 
 
 
Table 2-3. Typical reaction composition of sequencing PCR 
Volume per reaction 
Component 
PCR product Plasmid 
BigDye®  V3.1 4 μl 4 μl 
Primer (3.2 mM) 0.7 μl 0.5 μl 
Template DNA 0.7 μl (~3 ng) 0.2-1.0 μl 
Double Distilled Water 4.6 μl Variable 
Total Volume 10 μl 10 μl 
 
 
Table 2-4. Typical thermal cycler condition of sequencing PCR 
Condition 
Cycles 
PCR product Plasmid 
1 X 95℃, 3 minutes Skipped 
95 , 30 seconds℃  96℃, 10 seconds 
52.5℃, 10 seconds 50℃, 5 seconds 30-35 X 




2.5  Zebrafish genomic DNA preparation 
2.5.1 Prepare genomic DNA from adult zebrafish 
The adult zebrafish need to be starved for one or two days before the genomic 
DNA preparation. At the first day morning, the zebrafish was transferred into a Petri 
dish and anesthetized with ice or in egg water supplemented with tricaine. The 
internal organs were then removed with scissors and forceps. The remaining body was 
cleaned in PBST, weighed and transfer into a 15 ml Falcon tube containing 10 ml 
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adult zebrafish lysis buffer. The mixture was incubated in an oven at 55 ℃ for 
overnight with gentle shaking. In the next morning, the mixture was spun at 10000g 
for 15 minutes. the debris was discarded and the supernatant was split equally into 
two 15 ml Falcon tubes. The genomic DNA was prepared as described in the 
following steps.  
1. Add 5 ml phenol (pH 8.0) to each of the tube, shake for 10 min, and then spin 
at 10000g for 10min. Transfer the upper phase to two 15ml Falcon tubes. . 
2. Repeat step 1. The upper phase should be transparent after the repeating.  
3. Add 5 ml 1:1 phenol (pH 8.0) /chloroform to each of the tubes, shake for 
10min. Then spin at 10000 g for 10min. Transfer the upper phase to two 15 ml Falcon 
tubes. 
4. Add 5ml chloroform, shake for 10min, and then spin at 10000 g for 10min, and 
transfer the upper phase to two 15 ml Falcon tubes. 
5. For each of the tube, add 5 ml isopropanol and invert for several times for 
DNA precipitation. Use a clean stick (e.g. an inoculation stick) to collect the DNA 
(cloudy white) and transfer all DNA to a 2 ml microcentrifuge tube. 
6. Wash DNA with 1.5 ml 70% EtOH twice and then air dry the pellet. 
To make DNA stock solution, 1X TE buffer was added to the sample at 400ul per 
0.3g original tissue weight to the pellet. The mixture was stored in 4℃ for several 
days to dissolve, after which the DNA stock solution was put in -20℃ for long time 
storage. For PCR analysis, the DNA stock solution was diluted 200 times to be used 
as the template.  
 
2.5.2 Prepare genomic DNA from zebrafish embryos 
Genomic DNA from single zebrafish embryos were used as the template in 
PCR-based mapping. The zebrafish embryos were transferred into 96-well plate. For 
each of the well, 50 μl zebrafish embryo lysis buffer was added and then the plate was 
sealed with aluminum film. The lysis reaction was performed by incubating the plate 
on thermal cycler at 55 ℃ for 14 hrs, followed by boiling at 94 ℃ for 20 min to 
inactivate proteinase K. After spin down the debris at 1000 rpm for 5 minutes, the 
supernatant are used as PCR template immediately or stored in 4℃ for future use.  
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2.6  RNA extraction 
RNA extraction was performed by using TRIZOL Reagent (Molecular Research 
Center, Inc. Cat. No. TR118) following the manufacturer’s instructions. To get RNA 
sample of high quality, one more round of chloroform extraction was usually 
performed before isopropanol precipitation. The RNA concentration was determined 
using spectrophotometer (ND-1000, NanoDrop) and the RNA quality was evaluated 
by electrophoresis. 
 
2.7  Northern blot analysis 
2.7.1 Probe Preparation 
DIG-labeled DNA probe used in northern blot was generated by PCR method by 
using DIG DNA labeling mix (Roche, Cat. No. 1636090) according to the 
manufacture’s insert. Before use, probe was denatured at 100 ℃ for 10 minutes, 
followed by immediate incubation on ice and finally diluted in pre-warmed 
pre-hybridization buffer (DIG Easy Hyb, Roche Cat. No. 1 603 558) to a final 
concentration of 25 ng/ml. 
 
2.7.2 RNA sample preparation 
For each sample, 15 μg total RNA sample was transferred to 1.5ml Eppendorf 
microcentrifuge tube, vacuum dried and mixed with 15μl RNA loading buffer. After 
dissolving and denaturing at 65℃ for 20 minutes, sample was chilled on ice for 5 
minutes and then mixed with 2 μl RNA loading dye before loading on denaturing gel. 
RNA samples were loaded into the each well of the denaturing gel (Table 2-5) 
with approximately equal amount. An RNA molecular weight ladder (Invitrogen, Cat. 
No. 15620-016) was used as the size reference. The gel was run under 10-12 V/cm to 
a pre-determined length in 1X MOPS running buffer. After electrophoresis, the gel 
was rinsed in sterile water to remove formaldehyde and then soaked twice in 20 x 
SSC for 15 minutes each. Sample transfer was conducted by capillary methods in 20 x 
SSC buffer overnight to Hybond N+ membrane (GE Health care, Cat. No. RPN303B). 
After transfer, a UV crosslinker (Stratalinker, Stratagene) was used to fix the RNA on 
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the membrane. The RNA quantity and quality was evaluated by methylene Blue 
staining (MRC Cat. No. MB119). 
 
Table 2-5. 1.3% Denaturing RNA gel for northern blot analysis (50 ml) 
Component Volume 
Agarose 0.65 g 
10X MOPS 5 ml 
Double distilled water 42.3 ml 
Melt agarose, cool to ~50℃, then add 
Formaldehyde 37% 2.67 ml 
 
2.7.3 Hybridization analysis 
The membrane hybridization was performed in a hybridization tube or in a 50 ml 
Falcon tube. It was firstly pre-hybridized for 2 hours at 50 ℃ in pre-hybridization 
buffer followed by overnight incubation at 50 ℃ in hybridization buffer containing 
the probe. After hybridization, a series of membrane washes were carried out, 
including two 15-minute washes with 2x SSC, 0.2% SDS (W/V) at the room 
temperature, two 15-minute washes with 0.5x SSC, 0.2% SDS (W/V) at 68 , three ℃
washes with 0.1X SSC, 0.2% SDS (W/V) at 68 . ℃ After these membrane washes, the 
membrane was equilibrated in washing buffer (Roche) for 1-5 minutes and then 
soaked for 30-60 minutes in the blocking solution (Roche) followed by incubation 
with 1:20,000 anti- digoxigenin-AP, (Roche, Cat. No. 1 093 274, diluted by blocking 
solution) at the room temperature for 30 minutes. After antibody incubation, the 
membrane was washed six times in washing buffer for 15 minutes each and then 
equilibrated with the detection buffer for 3 minutes. The signal was developed by 5 
minutes room-temp incubation with CDP-Star (Applied Biosystems, Cat. No. 
160081-62-9) followed by film exposure in the dark room using HyperfilmTM ECLEM 
(GE Healthcare, Cat. No. RPN3114K) and a KODAK X-Omat 2000 film processor.  
Solutions used in northern blot RNA gel hybridization were from DIG Wash and 
Block Buffer Set (Roche, Cat. No. 1585762) and prepared following the 
manufacturer’s instruction.  
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2.8  5’ and 3’ RACE 
The FirstChoice® RLM-RACE kit from Ambion (Cat. No.1700) was used to 
clone the 5’ and 3’ ends of target genes. Experiments were carried out according to 
the manufacturer’s instruction. Zebrafish total RNA was used as the starting material. 
 
2.9  RT-PCR 
RT PCR was performed in a two-step manner. In the first step, cDNA was 
synthesized from total RNA using SUPERSCRIPT II RNase H- Reverse Transcriptase 
(Invitrogen, Cat. No. 18064-22) according to the manufacture’s instruction. In the 
second step, conventional PCR was performed by using the synthesized cDNA 
template and gene specific primer.  
 
2.10  Sectioning of zebrafish embryo 
2.10.1  Wax-embedded sectioning 
After fixation in 4 % PFA at 4℃ overnight, zebrafish embryos were washed 
briefly in PBST before being mounted in 1.5% agarose in small chambers (e.g., the 
caps of 1.5 ml Eppendorf tubes). The blocks were trimmed to the shape of pyramid 
with a surgical blade and then gradually dehydrated in ethanol solution and immersed 
in wax. After wax embedding, the samples were embed and mounted on plastic 
cassette for sectioning. Sections were cut serially at 4 μm thickness by using a 
Microtome (Leica, RM2165) and collected on pre-cleaned glass slides (EMS. Cat. No. 
71868-10). The slides were incubated on 37℃ hot plate for at least 2 hours before 
they were used immediately for standard H&E staining or stored in slide box at the 
room temperature for future use.  
2.10.2  Cryosectioning 
After fixation in 4 % PFA at 4℃ overnight, zebrafish embryos were washed 
briefly in PBST before being mounted in 1.5% agarose/30% sucrose in small chamber 
(e.g., the caps of 1.5ml Eppendorf tube). The blocks were trimmed to the shape of a 
pyramid with a surgical blade, and equilibrated in 30% sucrose overnight in 4℃. 
After equilibration, the pyramids were mounted in O.C.T. compound (Sakura Cat. No. 
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4583) in plastic molds and instant frozen to block in dry ice or liquid nitrogen. The 
frozen block can be used immediately or stored in air-tight box in -80℃ for several 
months.  
For cryosectioning, the blocks were mounted on the supporter (Leica, Cat. No. 
0.370.08587) with O.C.T. compound and equilibrated at -30℃ in a pre-chilled 
microtome (Leica, HM505) for 2 hours prior to sectioning. Sections were cut serially 
at 12 µm thickness and then collected on polylysine coated glass slides (Menzel, Cat. 
No. J2800AMNZ). The sections were dehydrated by incubation on a hot plate at 42℃ 
for 2 hours or overnight. After dehydration, the slides can be used immediately for in 
situ hybridization or immunofluorescence or stored in air-tight moisture protected 
chambers at –80℃ for several months.  
 
2.11  Cell culture 
2.11.1  Cell lines and growth condition 
The human cell lines used in this study were Hela cell and 293T cell. The 
compositions of their growth medium are given below. Cells were maintained in 10 
cm petri dishes or 75 ml cell culture flasks (Nunc) in 37℃ humid incubator 
supplemented with 5% CO2.  
Growth medium for Hela cells (500 ml): 400 ml of basic MEM (Media 
Preparation Unit, IMCB), 10 ml of 7.5% NaHCO3, 5 ml of 200mM L-Glutamine 
(Gibco. Cat. No. 25030-081), 5 ml of 1M Sodium-Pyruvate (Gibco. Cat. No. 
11360-070), 5 ml of non-essential amino acids (Gibco. Cat. No. 11140-050), 50 ml of 
FBS (Hyclone, Cat. No. SH30070.03), 5 ml of Penstrep (Gibco Cat. No. 15070-063).  
Growth Medium for 293T cells (500 ml): 450 ml of DMEM (4500mg/l glucose, 
Media Preparation Unit, IMCB), 50 ml FBS (Hyclone, Cat. No. SH30070.03), 5 ml of 
Penstrep (Gibco Cat. No. 15070-063). 
2.11.2  Subculturing cells 
Cells grown in the incubator were split twice a week for continuous maintenance. 
Before subculturing, cell density was examined by observing under a microscope. 
After brief washing with PBS, cells were trypsinized with 1 ml 0.125% trypsin (media 
preparation unit, Biopolis) and suspended with 9 ml cell culture medium. 
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Subculturing was carried out by add 2-3 ml of the suspended culture to new flask or 
Petri dish containing 10 ml of fresh medium.  
2.11.3  Cell transfection 
Transfection of cells with plasmid constructs was carried out using 
LipofectaimeTM 2000 regent (Invitrogen. Cat. No. 11668-019) following the 
manufacture’s instruction. For a typical transfection of a 10 cm Petri dish, 15 μl of 
lipofectamine regent and 6 μg of each plasmid constructs were used. Transfected cells 
were harvested between 24 and 48 hours post transfection for subsequent 
immunofluorescence or western blot analysis. 
 
2.12  Immunofluorescence 
Immunofluorescence is the labeling of antigen with fluorescent dyes. This 
technique is used to visualize the distribution of biomolecules of interest within live 
or fixed samples. In this study, immunofluorescence was carried out in fixed Hela 
cells as well as zebrafish sections fixed on glass slides.  
To perform immunofluorescence experiment, Hela cells were grown on 
coverslips in 6-well dish until they reach ~50%-60% maximum density, after which 
they were washed briefly with ice-cold PBS and then fixed in 4% PFA for 20 minutes. 
After fixation, the cells were rinsed in PBS for 10 minutes and then permeabilized in 
PBS containing 0.2% Triton X-100 for 10 minutes. To reduce the non-specific 
binding of antibodies, cells were blocked in 10% goat serum (Sigma, Cat. No. G9023) 
diluted in PBS containing 0.1% Triton X-100 for 10 minutes prior to incubation with 
primary antibody (1:100 dilution in blocking solution) for 2 hours at 37 ℃ or 
overnight in 4 ℃. The cover slips were then washed twice in PBS with 0.1% Triton 
X-100 for 10 minutes each with gentle shaking. After wash, secondary antibody 
conjuncated with fluorescein pore (Molecular Probes, Cat. No. A11001 and A11004, 
1:1000 diluted in blocking buffer) was added to the cells and incubated in dark at the 
room temperature for one hour. After three final washes in PBS with 0.1% Triton 
X-100, the clips were dried briefly in 37 ℃ oven and mounted in mounting medium 
(Vectorlabs, Cat. No. H-1200 and H-1300; Calbiochem, Cat. No. 345789). The 
immunofluorescence experiment on zebrafish sections was performed essentially the 
same as that in fixed Hela cells except that the solution used for blocking and 
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antibody dissolving was supplemented with 1% DMSO (Dimethyl Sulfoxide, Sigma, 
Cat. No. D8418). The final observing and image capturing of the samples were 
carried out using confocal microscopes (Zeiss LSM 510 or Olympus FluoView 1000).  
 
2.13  Western blot 
A western blot (alternately, immunoblot) is a method to detect protein in a given 
sample. It uses SDS-PAGE gel electrophoresis to separate proteins by their molecular 
weight. The proteins are then transferred from the gel onto a membrane where they 
are "probed" using antibodies specific to the protein. As a result, the size and amount 
of certain protein in the sample could be examined on the membrane. 
 
2.13.1  Protein sample preparation 
Protein samples used in this study were extracted from both cultured cells and 
zebrafish embryos. 
To extract protein from cultured cells (in a 10 cm Petri dish, for example), culture 
medium was removed from the Petri dish and then the cells were rinsed with 10ml of 
ice-cold PBS twice. Cells were harvested by scraping with 500 μl of mammalian cell 
lysis buffer and transferred into a 1.5 ml microcentrifuge tube. After topping up with 
5X lamini buffer to a final concentration of 1X, the lysate was boiled in heating block 
for 5 minutes and spun at the maximum speed in a desktop centrifuge for 5 minutes. 
The supernatant containing lysized proteins can be loaded for western blot analysis 
immediately or stored in freezer for future analysis.   
To prepare protein samples from zebrafish embryos, the dechorined embryos 
were rinsed briefly in ice-cold PBST and then transferred to 1.5 ml microcentrifuge 
tubes. The sample was homogenized in SDS sample buffer by sipping up ad down 
with syringe (1 ml) and needle (size 26G). The mixture was toped up with 5X lamini 
buffer to a final concentration of 1X and then boiled for 5 minutes on a heating block. 
The whole lysate was spun at the maximum speed in a desktop centrifuge for 5 




2.13.2  SDS PAGE gel running and membrane transfer 
The SDS PAGE gel was casted by using Mini-PROTEAN® Cell (Bio-Rad, Cat. 
No. 165-3301) following the manufacture’s instructions. The composition of SDS 
PAGE gel was shown in table 2-6.  
 
Table 2-6. Preparation of SDS PAGE gel 





30% Polyacrylamide 3.4 ml 3ml 30% Polyacrylamide 0.34 ml
Double distilled water 4 ml 4.4 ml Double distilled water 1.36 ml
1.5M Tris (pH 8.8) 2.5 ml 2.5 ml 1M Tris (pH 6.8) 0.26 ml
10% SDS 100 μl 100 μl 10% SDS 20 μl 
10% APS 100 μl 100 μl 10% APS 20 μl 
TEMED 10 μl 10 μl TEMED 3.5 μl 
 
5-20 μl of protein sample prepared from above was loaded to each of the well on 
the gel. A dual color protein ladder (Bio-Rad, Cat. No. 161-0374EDU) was loaded as 
the size reference. The gel running was conducted in 1X SDS PAGE running buffer. 
Typical running power conditions include starting at 70 volts (constant voltage) for 30 
minutes followed by 140 volts (constant voltage) for 1 hour and 15 minutes. After 
running to a predetermined length, the protein sample was transferred from gel to 
PVDF membrane (Millipore, Cat. No. IPVH00010) by using the Mini Trans-Blot® 
ElectrophoreticTransfer Cell (Bio-Rad, Cat. No. 170-3930) according to the 
manufacture’s instructions.  
 
2.13.3  Signal detection of target protein 
The membrane with protein sample was pre-stained with Ponceau S Solution 
(Sigma, Cat. No. P7170) to check the quality of gel running and transfer. The signal 
detection was performed by the two methods indicated in table 2-7. The rapid method 
was firstly use to adjust the suitable gel concentration, sample loading amount and gel 










Table 2-7. Methods for target protein detection in western blot analysis 
Rapid method Standard method 
1. Blocking Skipped 
1 hour at RT in     
1% BSA/PBST 
2. Primary Antibody 1 hour in RT 4℃ overnight 
3. Wash in PBST 
1 quick rinse plus 3 washes (5 
minutes each) 
1 quick rinse plus 6 
washes (5 minutes 
each) 
4. Secondary antibody 30 minutes in RT 30 minutes in RT 
5. Wash in PBST 
1 quick rinse plus 3 washes (5 
minutes each) 
1 quick rinse plus 3 
washes (5 minutes 
each) 
6. Substrate 1 minute 3 minutes 
7. Film exposure 15 seconds to 30 minutes 
1 seconds to 30 
minutes 
 
Table 2-7. The primary antibody was diluted in 1% BSA/PBST (Sigma, Cat. No. A7030) to a 
final concentration of 1:500 to 1:2000. The secondary antibody were purchased from Pierce and used at 
a concentration of 1:40000 (Pierce, Cat. No. 31460 and 31430). The signal was developed by using the 







2.14  In situ hybridization 
2.14.1 . Preparation of labeled RNA probes by in vitro transcription 
The probe labeling and purification was performed by in vitro transcription using 
RNA polymerase (Promega, Cat. No. P108B, P208C and P207B) and DIG RNA 
labeling mix or Fluorescein RNA labeling mix essentially as described in the 
manufacture’s literature (Roche, Cat. No. 11 277 073 910 and 11 685 619 910). After 
transcription the DNA template was eliminated by incubation with RNase-free DNase 
I (Roche, Cat. No. 10 776 785 001) for 15 minutes at 37 ℃. Probe purification was 
conducted via LiCl and ethanol precipitation method as described in the technical 
instructions of the labeling mix. After determining of concentration on 
spectrophotometer (ND-1000, NanoDrop), probes were diluted in hybridization buffer 
to a concentration of 0.5-2 μg / ml. Prior to use, hybridization buffer containing 
probes was heated at 80 ℃ for 5 min water bath, followed by instant chilling in ice 
for 10 minutes for denaturation. 
 
2.14.2  Whole mount in situ hybridization for phenotype 
characterization  
This protocol was designed for the obtaining of high quality image in phenotype 
characterization work. Although this method produces good signal and low 
background, it is both time and labor consuming.  
At day-1 afternoon, embryos stored in methanol in -20  were re℃ -hydrated 
gradually in PBST at the room temperature and then equilibrated in PBST for 2 X 10 
minutes. Embryos were digested in proteinase K (FINNZYMES, Cat. No. F-202L. 
1:1000 in PBST) to make permeable for probes, and then washed with PBST 2 X 10 
minutes and post-fixed in 4% PFA at the room temperature for 20 minutes. After 
post-fixation, embryos were washed 2 X 10 minutes in PBST and then incubated in 
pre-hybridization buffer in 68 ℃ oven with gentle shaking. Two hours later, embryos 
were transferred to pre-warmed probe and incubated in 68 ℃ oven with gentle 
shaking. 
At day-2 morning, probe was removed and collected for re-use. Embryos were 
washed in 68 ℃ oven with gentle shaking in a serial of solution as following 
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-2 X 20 minutes in 2 X SSCT/50% Formamide (pre-warmed)  
-1 X 20 minutes in 2 X SSCT/25% Formamide (pre-warmed) 
-2 X 20 minutes in 2 X SSCT (pre-warmed) 
-3 X 30 minutes in 0.2 X SSCT (pre-warmed) 
-2 X 5 minutes in PBST at RT 
After the final wash in PBST, embryos were blocked in blocking solution for 2 
hours at the room temperature, and then incubated with appropriate antibody 
(anti-DIG-AP or anti-Fluorescein-AP, 1/5000 in blocking solution) overnight at 4℃ 
with gentle shaking.  
Antibody was removed at day-3 morning and collected for re-use. Embryos were 
then washed at the room temperature with gentle shaking in a serial of solution as 
following 
-PBST rinse briefly 
-2 X 10 minutes in 1% BCS/PBST 
-3 X 30 minutes in 1% BCS/PBST 
-3 X 10 minutes in appropriate staining buffer 
After equilibration in staining buffer, embryos were stained in appropriate 
substrate in dark with gentle shaking at either the room temperature or 4℃ until signal 
become satisfactory. Finally the embryos were mounted in 100% glycerol for taking 
images.  
This in situ hybridization protocol was designed for phenotype characterization 
and can be modified to stain different organs with different colors. To achieve this, 
the hybridization buffer will contain mRNA probes with different labeling. For 
example, some labeled with DIG and the other with fluorescein. The signals of these 
two labels were developed separately. Usually, DIG labeled probe works better in 
hybridization than fluorescein labeled probe. So that after hybridization and blocking, 
the embryos will firstly be incubated with anti-fluorescein antibody and then develop 
color with FastRed substrate. Upon obtaining satisfactory signal, the embryos will be 
soaked in 0.2M Glycine (pH 2.2) at the room temperature for 10 minutes to kill the 
conjugated alkaline phosphatase on the first antibody. In the end, antibody incubation 
and color developing were repeated with anti-DIG antibody and BCIP/NBT substrate. 
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2.14.3  High throughput whole mount in situ hybridization for 
genetic screening 
This in situ method was developed for the genetic screening. It is a simplified 
version of the protocol for characterization. In brief, dehydration in methanol and 
rehydration of fixed embryos were skipped. Post-hybridization washes consisted of 2 
x SSCT wash at 68℃ for twice at 15 minutes each, followed by 0.2 x SSCT wash at 
68℃ for three times at 15 minutes each and finally rinsed in room-temp PBST for 15 
minutes. Antibody incubation was carried out with at a concentration of 1/2000 in 
blocking solution at the room temperature for two hours, followed by three 
20-minutes washes in PBST at the room temperature. 
This method consumes less time and labor at the cost of higher background as 
compared with the characterization protocol. However, it is definitely enough for 
genetic screening and similar applications which does not require high quality of 
image.  
2.15  Microinjection 
2.15.1  Preparation of mRNA, morpholino, and needles 
The mRNAs used in microinjection were prepared by in vitro transcription. The 
coding sequence of target gene was inserted into the pCS2+ plasmid vector which 
contains a SP6 promoter and a SV40 polyA signal. The linearized construct was used 
as the template for capped mRNA synthesize by using the mMESSAGE 
mMACHINE® SP6 Kit (Ambion, Cat. No. #1340) following the manufacturer’s 
instruction. After purification, capped mRNA was aliquoted in small quantities (2 μl 
per aliquot at a concentration of 2-4 μg/μl) and stored at -80 ℃.  
Gene specific morpholinos and zebrafish standard control morpholino were 
designed and synthesized by Gene Tools (www.Gene-tools.com). Mopholinos were 
dissolved in sterile water as 5 mM stock and then further aliquoted in 2 μl/tube and 
stored in -20 ℃.  
The needles used for microinjection were made from borosilicate glass capillaries 
with an internal filament (Sutter Instrument, Cat. No. BF100-58-10). They were 
pulled by micropipette pullers (Sutter Instrument, P97) following the manufacture’s 
instruction. Needles were broken under a dissection microscope by using fine forceps 
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or a surgical blade to an outer diameter of 20 μm and a tip shape that resembles a 
surgical needle. 
 
2.15.2  Microinjection 
The microinjection manipulator (PLI-100, HARVARD APPARATUS) and 
nitrogen bottle were switched on 20 minutes prior to the experiment. The injection 
pressure was adjusted between 10 and 20 psi (pound per square inch), depending on 
the injection volume and the diameter of the needle, to reach a one nano liter (nl) 
volume per injection as measured by measuring with a millimeter ruler under a 
microscope. The injection balance pressure was set between 0.2-0.4 psi to prevent 
medium flowing back into the needle. RNA or Morpholino was diluted with phenol 
red and sterile water to reach appropriate concentrations before being loaded by 
Microloader pipette tips (Eppendorf Cat. No. 5242 956.003) from the back opening of 
the needle. 
The injection was carried on 1-cell stage or earlier zebrafish embryos which were 
either sorted on the furrows of E3 medium/1.5% agarose dishes, or aggregated to 
form a single layer of embryos on the inner surface of a Petri dish. The needle is fixed 
on and operated by manipulator. It should be thrust swiftly into the centre of the yolk 
(not the chorine!) and once it reached, the foot pedal of the manipulator was pressed 
to make one injection. The needle should stay in the yolk for 1-2 seconds after each 
injection to prevent the leaking of the injected contents. After all the injections were 
made, the embryos were transferred to E3 medium and incubated at 28.5 ℃. 
 
2.16  Alkaline phosphatase staining 
Embryos were fixed in 4% PFA/PBST for 2 hours at the room temperature. After 
fixation, the embryos were washed in PBST for 2X 10 minutes and then soak in 
pre-chilled acetone and stored in freezer for 30 minutes. After the acetone treatment, 
the embryos were rinsed in PBST for 2X 5 minutes, equibrilated in NBT/BCIP 
staining buffer for 10 minutes and then stained in NBT/BCIP solution until signal 
became satisfactory.  
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2.17  Alcian blue staining 
Embryos were fixed in 4% PFA/PBST for 2 hours at the room temperature, and 
then transferred into a 0.1% solution of alcian blue (Sigma. Cat. No. ) dissolved in 
80% ethanol/20% glacial acetic acid to stain overnight. After staining, the embryos 
were rinsed in ethanol and rehydrated gradually into PBST. Tissue was removed by 
digestion in 0.125% trypsin (Media Preparation Unit, IMCB) for several hours. 
Pigmentation was bleached in 3% hydrogen peroxide. Stained samples were mounted 
in 87% glycerol for image capturing.  
  
2.18  Transmission Electron Microscopy (TEM) 
The TEM service is provided by Department of Biological Sciences, National 
University of Singapore. In brief, 5 dpf zebrafish embryos were fixed in 2% 
glutaradehyde and 1% PFA in PBS for 2 hours at the room temperature and postfixed 
in 1% osmium tetroxide for 1 hour at the room temperature. After fixation, the 
samples were gradually dehydrated with ethanol (sequentially in 1X 30%, 1X 50%, 
1X 70%, 1X 90%, 3X 95%, 1X 100%) and embed individually to resin blocks. 50 nm 
cross-sections of interested organ or tissue were trimmed from the embedded sample 
with an Ultracut E microtome (Leica). The ultra-thin sections were collected on 
copper grids (Structure Probe, Inc, Cat. No. 2010C) and stained with 5% uranyl 
acetate and 2% lead citrate. The observation and image acquiring were performed on 
a Philips CM-10 transmission electron microscope.  
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Chapter 3. Genetic screening for zebrafish mutants with liver 
defects 
 
3.1  Introduction 
Zebrafish is an excellent model system to study vertebrate embryogenesis via 
forward genetic approaches. In our lab, we wish to use this small teleost to study 
embryonic development of the liver. For this purpose, a moderate scaled ENU 
mutagenesis and genetic screening in zebrafish for identification of liver mutants was 
conducted in our group in 2001.  
The process of mutagenesis and screening is illustrated in Figure 3-1. The 
wild-type zebrafish AB line was used as the founder fish for the mutagenesis. 
Chemical mutagen ethylnitrosourea (ENU) was used to generate hundreds of point 
mutations in the male premeiotic germ cells (spermatogonia) (Knapik, 2000). 
ENU-treated males were crossed with wild-type females to produce the F1 
heterozygous progeny. F1 males were then crossed with wild-type females to generate 
F2 families, in which half were genotypically heterozygous for a specific mutation 
(+/m), whereas the other half were wild-types (+/+). F2 sibling were inter-crossed 
randomly, so that the resulting F3 progeny of two heterozygous F2 parents would be 
25% wild-type (+/+), 50% heterozygous (+/m) and 25% homozygous (m/m) for a 
recessive mutation (Patton and Zon, 2001). 
Genetic screening was facilitated by RNA WISH (whole mount in situ 
hybridization) with liver specific markers to illustrate the liver size and shape in 
zebrafish embryos. Initially, liver phenotype of 3 days post fertilization (dpf) 
zebrafish embryos was investigated with prox1 probe, which has strong expression in 
the liver at this stage. Assuming that the liver will appear abnormal in size and/or 
shape if an essential gene for its development is mutated, we can easily identify liver 














Figure 3-1. Schematic show of mutagenesis, crossing and screening. Males mutagenized with 
ENU were mated to wild-type females. The F1 progeny raised from matings 3 weeks after the mutagen 
treatment (resulting from treatment of spermatogonia) was heterozygous for one mutagenized genome. 
An F2 generation was raised from sibling matings. A mutation m present in one of the F1 parents was 
shared by 50% of the fish in the F2 family. Eggs were collected from a number of matings between 
sibling fish. If both parents were heterozygous for m, expected in 1/4 of the crosses, 1/4 of the eggs 
will be homozygous and show the mutant phenotype (Haffter et al., 1996).
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As shown in Figure 3-1, putative heterozygous of a mutation could be found in 
F2 family in theory. However, ENU mutagenesis usually generates hundreds of point 
mutations into the genome (Knapik, 2000). Thus a phenotype appeared in F3 family 
might be the combinational effects of a group of mutations. To facilitate the future 
gene cloning and characterization work, outcross is necessary to purify the genetic 
background and at the same time, maintain the putative mutant lines to the next 
generation. Outcross is to cross heterozygous fish to the wild-type fish. The progeny 
were raised to sex maturity. The heterozygous among them were pick out by random 
crossing and in situ screening to be used in a new round of outcross. In such a way the 
undesired point mutations were diluted in the zebrafish genome generation by 
generation. In theory, six rounds of outcross could ensure the link between phenotype 
and mutation in a candidate mutant line. However, normally 3-4 rounds of outcross 
are already good enough for the purpose of positional cloning of the mutated gene. 
By the time I joined Dr Peng’s group and took in charge of the screening project 
in September 2003, mutagenesis and two rounds of genetic screening had been 
finished by my colleagues and collaborators. 71 putative mutant lines from 54 F2 
families were generated. My initial task was the maintenance and reconfirmation of 
these mutants by using the methods introduced earlier in this chapter. 
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3.2  Materials and Methods 
The main materials and methods are described in Chapter 2. 
The RNA probes used in this part are prox1 and lfabp (liver fatty acid binding 
protein) for the liver, ifabp (intestinal fatty acid binding protein) for the intestine, 
insulin for the islet and trypsin for the exocrine pancreas. The detailed information 
about the probes is listed in Appendix 1. 
 
3.3  Results 
3.3.1  67 out of 71 putative mutant lines were reconfirmed 
Outcross and a third round of genetic screening was performed on the 71 putative 
mutant lines with the same method as that used in our earlier screening. Finally 67 
putative mutant lines were confirmed, which can be phenotypically classified into 
three groups as the following:  
Group A: 3 lines. The homozygous mutant fish look normal at 3 dpf, but no 
presence of liver can be observed by prox1 staining (Figure 3-2 A). 
Group B: 18 lines from 12 F2 families. The mutants exhibit small-liver phenotype 
(less than half of the normal size) and generally look normal (Figure 3-2-B). 
Group C: 46 lines from 32 F2 families. The mutants exhibits no-liver or 
small-liver phenotype, but what more significant is their generally abnormal 
appearance. Most of them have either a small head or a short and curved trunk or both 








Figure 3-2-A. Putative mutants in Group A. This figure illustrated all 3 putative mutants that 
exhibit no-liver phenotype. The mutant names are indicated as the numbers on the left column. The 
general appearance and the prox1 expression in central nerve system (CNS) of these mutants are 
normal. However as the red arrow indicated, the prox1signal is totally absent in the region that 




Figure 3-2-B. Putative mutants in Group B. This figure illustrated examples of the 12 putative 
mutants that have small-liver phenotype. The mutant names are indicated as the numbers on the left 
column. The general appearance of the mutants and the prox1 expression in central nerve system (CNS) 
of these mutants are normal. However, as the red arrow indicated, liver in these mutants is much 






Figure 3-2-C. Putative mutants in Group C. This figure illustrated 3 examples of the 32 
putative mutants in group C. The mutant names are indicated as the numbers on the left column. 
Although they have significant liver defects (red arrow), the general appearance of these mutants is 
abnormal, exhibiting obvious smaller head, slimmer trunk and shorter body length compared with the 
wild-types.  
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3.3.2 Preliminary characterization of mutants in group A and B 
In consideration of our limited space and personnel in the lab, and also the 
relevance of their phenotype with our major purpose, the mutants in group C were 
eventually discarded. Among the mutant lines in group A and B, two lines (181 and 
264) were selected to perform positional cloning work by my colleague Mr. Huang 
Honghui. For the rest of the mutants, some preliminary characterization work were 
carried out on them in order to have a deeper and more detail view into their 
phenotype.  
Four organ specific markers, lfabp for the liver, ifabp for the intestine, insulin for 
the islet and trypsin for the exocrine pancreas, were used in the preliminary 
characterization. WISH was performed with the original protocol as introduced in 
Chapter 2. To magnify the phenotypic differences between wild-type and mutant, 
embryos at 4 dpf were used for WISH instead of at 3 dpf which was used in our 
earlier genetic screening. The result of those characterizations is summarized in table 
3-1. After the preliminary characterization, the mutants in group B could be further 
classified into 5 categories by the combinations of their intestine and pancreas 


























Table 3-1. Summary of preliminary characterization result 








63 Reduced Reduced Reduced Normal 
74 Largely reduced Reduced Largely reduced Normal 
87 Reduced Absent Absent Normal 
90 Almost absent Reduced Slim Normal 
118 Reduced Reduced Reduced Normal 
121 Almost absent Largely reduced Almost Absent Normal 
147 Almost absent Reduced Almost Absent Normal 
152 Reduced Largely reduced Reduced Normal 
163 Almost absent Reduced Slightly reduced Normal 
187 Almost absent Reduced reduced Normal 
198 Reduced Slightly Reduced Slightly Reduced Normal 
202 Absent Reduced Reduced Normal 




































Figure 3-3 Further classification of mutants in Group B. Mutants in Group B can be further 
classified into 5 sub-categories by the combinations of their intestine and exocrine pancreas phenotype 
as revealed by the expression of ifabp and trypsin respectively. A. Mutant with slightly affected 
intestine and exocrine pancreas. B. Mutant with slightly affected intestine but severely affected 
exocrine pancreas. C. Mutant with no ifabp signal and severely affected exocrine pancreas. D. Mutant 
with no trypsin signal and severely affected intestine. E. Mutant that has neither ifabp nor trypsin 
signal. 
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3.4  Discussion 
This chapter briefly introduced the forward genetic screen project for the 
liver-defective zebrafish mutants in our group. After three years of effort, 17 liver 
mutant lines were finally generated. These mutants are invaluable resources for study 
liver organogenesis.  
During the genetic screening, the 17 mutant lines were initially classified into two 
groups according to their liver phenotype. After preliminary characterization with the 
four major digestive organs in these mutants, their phenotypes are found to be 
diversified (Table 3-1, Figure 3-3). These results gave us a lot of insights of the 
complicated regulatory network of organogenesis. Firstly, a lot of genes must be 
involved in this process. Although we have got more than a dozen liver mutants, it is 
obvious that our moderated scaled mutagenesis and screening project is far from 
saturation, which means that more genes essential for this process are still in myth. 
Secondly, the regulatory roles of these genes may be at different stages. For example, 
the genes that cause no-liver phenotype probably act earlier than liver specification 
and budding, while those that cause small-liver are more likely to repress the 
subsequent expansion growth. Thirdly, the same gene may affect the development of 
different organs. This is easily demonstrated by the significant pancreas and intestine 
phenotypes of our mutants, even though our genetic screening was initially focused 
on liver phenotype only. In addition, no mutant in our collection exhibit observable 
defect in islet. This is probably because that islet development is specified at a much 
earlier stage of embryonic development which was not covered in our screening 
(Biemar et al., 2001).  
Obtaining of mutants with expected phenotypes is just the initial step to use 
zebrafish as the liver model. The detailed mechanism study must be based on 
successful positional cloning of the mutated genes, which is going to be introduced in 




Chapter 4. Positional cloning of sec13sq198 
4.1  Introduction 
Positional cloning, or recombinant mapping, is a map-based approach used to 
isolate genes that cause phenotypes. Its principle is that the distance between a genetic 
marker and the mutation site is correlated with their co-segregation pattern during 
meiosis. To perform a positional cloning work, the mutation carriers were crossed 
with another line, which is called the mapping line, to generate the mapping family 
from which mutant embryos were collected to evaluate the co-segregation pattern 
based on the polymorphism between the founder line and the mapping line. For this 
reason, high density genetic maps and genomic information are highly desirable for a 
successful positional work. For the zebrafish system, several sets of genetic maps and 
thousands of genetic markers have been developed (Postlethwait et al., 1994). The 
most widely used genetic marker in zebrafish positional cloning work is the SSLP 
marker (simple sequence length polymorphism), which uses PCR primer pairs to 
flank microsatellite repeats in the genome. The length of the repeats reflects 
polymorphism between the founder line and the mapping line and can be scored on 
agarose gel after PCR amplification. The Zebrafish (Danio. rerio) Genome 
Sequencing Project in the Sanger Institute http://www.sanger.ac.uk/Projects/D_rerio/ 
is still on going. So far ~75% of total genomic sequence in zebrafish has been covered 
by the project. From the first successful positional cloning work in zebrafish in 1998 
(Kaestner et al., 1999) to today, quite a few genes essential for development have 
been successfully isolated via mutagenesis, screening and positional cloning approach 
(Donovan et al., 2000; Ober et al., 2006; Mayer and Fishman, 2003).  
In this project, the zebrafish liver mutant line 198 (m198) was selected for 
positional cloning work based on the results of screening and initial characterization. 
Homozygous zebrafish mutant m198 exhibit a small-liver and slightly small-head 
phenotype at 3 dpf (Figure 4-1). The development of its intestine and exocrine 
pancreas is also moderately affected as checked at 4 dpf (refer to Table 3-1 and Figure 











Figure 4-1. 3 dpf prox1 staining in m198. This figure illustrated the prox1 expression 
pattern in 3 dpf m198 mutant embryos. As indicated by the red arrow, the liver in the 
mutant is significantly smaller than that in the wild-type. In addition, the mutant also 
exhibits a slightly smaller-head and short body length as compared with the wild-type.  
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4.2  Materials and methods 
General materials and methods are introduced in chapter 2.  
The mapping genetic marker set (mapping panel), is kindly established by Mr. 
Huang Honghui (Appendix 2).  
The strategy design of the positional cloning work was modified from a protocol 
from the Zon Lab (http://zon.tchlab.org/) (Bahary et al., 2004).  
 
4.2.1 Preparation of mapping pairs 
Our mutants were generated from the AB line. In order to generate mapping 
family, two heterozygous pairs (198-4 and 198-15) from the 4th generation of m198 
were used to cross with two wild-type WIK pairs (WIK A-2 and WIK C-5). In total, 
four mapping families were generated (198-4 ♂ X WIK-C1 ♀, 198-4 ♀ X WIK-C1 ♂, 
198-15 ♂ X WIK-A2 ♀, 198-15 ♀ X WIK-A2 ♂). Once a mapping family reaches 
three months age, sibling crosses were set to identify m198 heterozygous fish which 
were kept in pairs (mapping pairs) in individual tanks. 
 
4.2.2 Mapping genomic DNA preparation 
Mapping pairs were crossed on Wednesday afternoon and embryos were 
collected on Thursday morning. On the next Monday morning, the 4 dpf embryos 
were fixed and subject to RNA situ hybridization with lfabp probe. After that, all 
mutant embryos were picked out manually under a dissection microscope and then 
transferred individually into 96-well plates with their origin recorded in detail. All 
sibling embryos were discarded thereafter except for those used to be used in the 
sibling pools. The genomic DNA preparation and storage was performed as described 
in Chapter 2. Usually, genomic DNA from 1000 or more individual mutant embryos 
are needed for a successful positional cloning project. 
Genomic DNA from the grandparents (the 4 pairs of adults used for generating 
the mapping families) is an essential reference for the positional cloning work. Upon 
the obtaining of enough mapping population, the grandparents were sacrificed for 
genomic DNA extraction as described in Chapter 2. 
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4.2.3 Strategy for mapping 
4.2.3.1  Rough mapping 
Rough mapping aims to locate the mutation site on a specific linkage group (LG). 
The bulk segregation analysis (BSA) was used (Figure 4-2) (Michelmore et al., 1991) 
to make the process faster. The principle of BSA is to use pooled genomic DNA 
instead of genomic DNA from single embryo to test all the markers in the mapping 
panel, a process usually referred to as “genome scanning”, which makes it easier to 
identify loosely linked markers. In this project, two mutant genomic DNA pools and 
two sibling genomic DNA pools were used for the rough mapping. Each pool contains 
a genomic DNA mixture of 24 embryos from the offspring of the same mapping 
family (Figure 4-3).  
The genome scanning consists large numbers of PCR reactions, in which genetic 
markers and the genomic DNA samples were arrayed in 96-well plate as shown in 
Figure 4-4-a and Figure4-4-b. The PCR reactions were performed as introduced 
previously and the products were fractionated on the high resolution gel [3.5% MS-8 
Agarose (CONDA, Cat. No. 8064) in 0.5X TBE]. One example of the gel image is 






Figure 4-2. Principle of bulk segregation analysis (BSA). A good SSLP marker for positional 
cloning should have significant difference in their PCR product sizes which are scorable on agarose gel. 
As indicated in the figure, this marker represents a genomic location that has significant polymorphism 
between AB line and WIK line. a. If the marker is un-linked with the mutation, then the AB band and 
the WIK band should have similar chance to be amplified from the mutant pool genomic DNA. b. If 
the marker is on the same chromosome with the mutation but not very close, the AB band should have 
more opportunity to be amplified in the mutant pool genomic DNA than the WIK band has. c. If the 
marker is tightly linked with the mutation, then the major band that can be amplified from the mutant 
pool genomic DNA should be the AB band. 
 
 
Figure 4-3. The composition of mapping pools. Two mutant genomic DNA pools and two 
sibling genomic DNA pools were used in initial mapping work. All embryos were lysized with the 
same amount of lysis buffer in individual wells in a 96-well plate. A mapping pool is generated by 
mixing of the same amount of DNA aliquots from 24 embryos of the same mapping family in a 1.5ml 
Eppendorf tube. Candidate linked markers identified in the genome scanning will be tested on all 








Figure 4-4. Format of genome scanning. The two mapping pools were arrayed on 96-well plate 
as indicated in a. The genetic markers were arrayed on 96-well plate as indicated in b. In such a format, 
each 96-well PCR reaction will represents the scanning result of 12 markers. The gel loading is 
facilitated by 8-channel pipette. The region highlighted in yellow will appear in gel image as shown in 
c, which helps to interpret the result easily. 
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4.2.3.2  Intermediate mapping 
In a favorable situation, rough mapping could locate the mutation to a certain 
linkage group (LG) with one or two genetic markers in the mapping panel, after 
which intermediate mapping could be started. Firstly, all existing SSLP markers 
within that region will be firstly checked with grandparent genomic DNA to select the 
ones that could represent polymorphism between the founder line and the mapping 
line. Secondly, the selected new markers will be tested on all mapping genomic DNA 
samples to identify those who indicated recombinant events (recombinants). In such a 
way, a genetic map can be generated revealing the relationship between the mutation 
and existing SSLP markers. Meanwhile, the remaining recombinants between two 
closest markers will be used in the subsequent fine mapping. 
 
4.2.3.3  Fine mapping 
Fine mapping, which is also referred to as “chromosome walking”, works in a 
step-in manner to further narrow down the mutation by two flanking markers into a 
critical genomic region that can be characterized at molecular level to identify 
mutations (Figure 4-5). Firstly, the sequence information of the nearest existing 
markers revealed during intermediate mapping will be used in database search to find 
their physical positions on zebrafish genome, which usually results in a group of 
BACs (bacterial artificial chromosome) or Contigs (assembly of overlapping BACs). 
Secondly, new candidate SSLP markers will be designed according to the sequence 
information of these BACs and Contigs. As performed in the intermediate mapping, 
those markers will be tested on grandparents DNA and the successful candidates will 
be used to further narrow down the mutation.  
In this project, the genomic sequence information comes from NCBI as well as 
the zebrafish genomic sequencing project in Sanger Institute 
(http://www.sanger.ac.uk/Projects/D_rerio/). The web-based primer annotation 















Figure 4-5. Schematic show of the Fine Mapping strategy. 
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4.2.3.4  Candidate gene approach 
 Candidate gene approach is the last step in the positional cloning work. Usually, 
fine mapping could locate the mutation in a genomic region less than several hundred 
kb (kilo base pair). Then genomic analysis will be performed on the last critical 
region to annotate all putative genes and ORFs (open reading frames) within the 
region, from which candidate genes are selected. cDNA sequences of all candidate 
genes from WT and mutant will be compared to find out the genes that carries the 
mutation. Finally the mutation site will be confirmed by comparing the sequences of 
genomic DNA from mutant and wild-type samples. 
 
4.3  Results 
4.3.1 Genome scanning to identify SSLP markers flanking the mutation 
in m198 
All 241 SSLP markers in our mapping panel were used to perform genome 
scanning on two independent sets of mapping genomic DNA pools. The result 
indicated that two SSLP markers in linkage group 22, z230 and z10321, co-segregate 
with the phenotype in m198 (Figure 4-6). In the existing genetic maps, dozens of 
SSLP markers were identified within or near the genetic region between z230 and 
z10321 (Figure 4-6). Test of PCR patterns of these markers with grandparents 
genomic DNA revealed that two new markers, z21243 and z42708B, showed 
polymorphism and thus could be used in mapping. To determine their relative 
position with and their direction to the mutation site, these markers were used to test 
on individual genomic DNA sample in the mutant pools. The results suggested that 

















Figure 4-6. Linkage analysis between m198 mutation and SSLP markers on the linkage 
group 22. The two markers used in the initial BSA are highlighted in red, they displayed 
co-segregation pattern in both of the DNA pools for BSA. Note each of the two new markers only 
showed clear polymorphism in one BSA pool but no in another. However, the linkage is very obvious 
in BSA PCR. This figure was composed based on the zebrafish genetic map of LG22 from MGH 











Figure 4-7. The m198 mutation is flanked by z10321 and z42708B. Marker z230, z10321 and 
z42708B were tested on the individual mutant genomic DNA samples from one of the BSA mutant 
pools (total 16 mutants). As showed by the gel image, z230 have two recombinants, among which one 
is shared by z10321. This result indicates that these two markers are located on the same side to the 
m198 mutation site, and z10321 is the nearer one. Another marker z42708B have only one recombinant 
which is not shared by either z230 or z10321. Therefore, it is located on the other side to the m198 
mutation site. Thus the m198 mutation is flanked by z10321 and z42708b in a short genetic region of 
~3.4 centimorgan (CM) as indicated by the genetic map in Figure 4-6. 
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4.3.2 Intermediate mapping 
As introduced in materials and methods part, the nearest rough mapping markers 
were used to test on all individual mutants in mapping population to identify 
recombinants. In total, 1332 individual mutant genomic DNA samples, which 
represent 2664 meiosis events, were tested. The result is shown in the table 4-1. 
 
North marker South marker 











1 1 95   18 95 
2 2 95   16 95 
3 2 95   12 95 
4 2 96   23 96 
5 2 96 2 96   
6 3 95 3 37 13 58 
7 3 96 3 96   
8 3 96   19 96 
9 1 96 10 96   
10 0 95   21 95 
11 1 93   21 93 
12 2 94   11 94 
13 1 96 1 96   











Table 4-1. Intermediate mapping.  The north marker z10321 and south marker z42708b 
and z21243 were used in intermediate mapping. The genomic DNA samples that showed 
recombination events for these markers were picked out and stored in new 96-well plates to facilitate 
future fine mapping. 
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4.3.3 Fine mapping located the m198 mutation to a genomic DNA 
region of ~54 kb 
Fine mapping was performed essentially as described in the materials and 
methods. Firstly, sequence information of the two nearest rough mapping markers, 
z10321 and z42708B, was retrieved from the MGH Zebrafish Server 
(http://zebrafish.mgh.harvard.edu/ ) and was used to blast the zebrafish genomic 
sequence in NCBI data base and the Sanger Institute. The result suggested that these 
two markers were located in a region covered by two overlapping Contigs consisting 
seven fully sequenced BACs (Figure 4-8).   
 
 
Figure 4-8. Contig view of the region harboring the m198 mutation. Rough mapping marker 
z10321 and z42708B were found to be located in two overlapping Contigs (red dashed rectangle) from 
Sanger Institute, which was covered by seven fully sequenced BACs (highlighted in. yellow)  
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The sequence information of these seven fully sequenced BACs was put into the 
web-based primer annotation software (http://danio.mgh.harvard.edu/markers/ssr.html) 
to find new markers. After confirming their polymorphism between AB and WIK 
lines, the selected new markers were used to test on remaining recombinants resulted 
from the intermediate mapping. Finally, the mutation site was found to be flanked by 






Figure 4-9. Fine mapping. A. Schematic show of the relative positions of 6 mapping markers 
with respect to the mutation site (red arrow) based on mapping result. B. The gel image of the closest 
north and south markers, the recombinants are indicated by black arrow. The red star indicates an 
apparently false selected embryo. 
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4.3.4 m198 carries a point mutation in sec13 gene 
Fine mapping located the mutation in a single fully sequenced BAC 
CH211-257F16. The 54.3 kb genomic DNA sequence flanked by the closest markers 
257E and 257H was retrieved from Sanger Institute and put into GENESCAN 
(http://genes.mit.edu/GENSCAN.html) as well as NCBI (BLASTx) to annotate 



























Table 4-2. Putative genes encoded by the DNA region defined by the last two 
markers. GENESCAN predicted four peptide from the 54.3kb genomic DNA. Their identity and 
functional information were obtained from NCBI protein database (BLASTp).  
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Among the four predicted genes, sec13 functions in the conserved COPII 
complex which is responsible for protein transport from endoplasmic reticulum (ER) 
to Golgi body (Tang et al., 2005). TIP-120A is relatively understudied but is known to 
express in the mouse liver (Yogosawa et al., 1999). We firstly selected them as 
candidate genes and started to compare their wild-type and mutant cDNA sequences 
via molecular cloning and DNA sequencing as introduced in chapter 2.  
TIP-120A cDNA was cloned and sequenced, however, no difference was found 
between mutant and wild-type TIP-120A cDNA. Excitingly, eight excessive 
nucleotides were found in mutant sec13 cDNA (Figure 4-10-A). Considering that 
ENU mutagenesis usually causes single nucleotide change (Knapik, 2000), the eight 
nucleotides is unlikely caused by the mutation directly. Genomic DNA sequencing 
revealed that in the mutant genome, there is a thymine to adenine transition mutation 
in an intron/exon junction of sec13 coding region, which creates a new pre-mRNA 
splicing site that induces eight nucleotides from an intron into the final mRNA 
product (Figure 4-10-B). The new splicing site is dominant over the native one thus in 
the subsequent cloning and sequencing for result confirmation, no wild-type splicing 
product was found in nearly 100 cDNA clones derived from 5 dpf mutant total RNA. 
By prediction, the mutant sec13 mRNA would result in a carboxyl-terminal truncated 







Figure 4-10. sec13 is mutated in m198. A, he wild-type zebrafish sec13 coding region is 963 
nucleotides in length. The mutant has eight excessive nucleotides start from position 706. B, in the 
mutant sec13 gene, a thymine to adenine transition in intron (highlighted in yellow block and yellow 
arrow head) forms a new splicing site (underlined in red), which introduced the 8 intronic excessive 















Figure 4-10. sec13 is mutated in m198. C. The mutant mRNA encodes a carboxyl-terminal 
truncated protein.  
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4.3.5 The mutation in sec13 gene caused the phenotype in mutant line 
198 
4.3.5.1  Mutant phenotype can be rescued by wild-type sec13 
mRNA injection 
mRNA over-expression to rescue the phenotype is a routine way to test the 
correlation of a gene to a phenotype. In the rescue experiment of this project, in-vitro 
transcribed wild-type and mutant sec13 mRNA was injected into embryos derived 
from heterozygous crossing at one cell stage, respectively. After injection, the 
embryos were raised under normal condition to ~3.5-4 dpf and the injected embryos 
were then analysized via RNA WISH with the liver specific marker lfabp probe. 
Sample images and statistical data from one of the rescue population were shown in 
figure 4-11. The rescue experiment was repeated three times and in total, 144 out of 





















Figure 4-11. Wild-type sec13 mRNA can rescue the m198 phenotype. Representative embryos 
from one of the rescue population were shown. Wildtype and mutant mRNA was injected at a 
concentration of 0.5 μg/μl. All embryos were genotyped and the result showed that: A. Wild-type sec13 
mRNA can rescue the mutant phenotype. According to the genotyping results in this population, there 
are in total 26 mutants, among which 11 were rescued partially and 6 were rescued fully as evaluated 
by their liver size and general appearance. B. sec13sq198 mRNA can not rescue the mutant phenotype. 
As the genotyping results indicated, among the 20 genotyped mutants within the population, none was 
rescued either partially or fully.  
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4.3.5.2  Mutant Phenotype can be mimicked by morpholino injection 
Gene specific knockdown by morpholino injection is an effective approach to 
study gene function in the zebrafish system. Firstly, an ATG morpholino was used to 
knockdown endogenous sec13. Unfortunately, the ATG morpholino caused 
embryonic death before the onsite of hepatogenesis at very low concentration. Then 
two splicing morpholinos were designed according to the zebrafish sec13 genomic 





Figure 4-12. Test of sec13 splicing morpholino. A. Initially, two sec13 splicing morpholinos, 
sp2 and sp3, were initially designed for the mimicking of mutant phenotype in wild-type embryos. 
Their targeting sequences (highlighted in purple) are the two exon (exon 7 and exon 8, blue font) and 
intron (intron 7, yellow font) junctions near the mutation site. Sequencing result indicated that sp2 will 
lead to mRNA mis-splicing from a new site in the exon 7 (highlighted in red), which results in a 66 bp 
in-frame deletion. On the contrary, sp3 will lead to intron insertion which creates a pre-mature stop 
codon. B. RT-PCR was performed to evaluate the efficiency of the two morpholinos. Apparently, sp2 
morpholino works effectively at 3.5 dpf when injected at a relatively low concentration, but not sp3 
morpholino. 
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According to the test result, a splicing morpholino, sec13-sp2, was used for the 
phenotype mimicking. For all the mimicking experiments, s standard control 
morpholino (5’-CCTCTTACCTCAGTTACAATTT-3’)(Chen et al., 2005) was 
injected as a negative control. The mimicking experiment was conducted on wild-type 
AB embryos essentially as described in the materials and methods part. The 
concentration of sp2 morpholino used in the mimicking is 0.2 nM. The standard 
control morpholino was injected at the same concentration. The result indicated that 
injection of sp2 morpholino into wild-type zebrafish embryos caused a small liver 
phenotype (Figure 4-13) which is comparable with that in mutant line 198, but the 





Figure 4-13. Morpholino mimicking. This image showed the WISH result from a morpholino 
injected population. The liver is indicated with blue arrow. At 3-3.5 dpf, the sp2 morphants exhibit a 
small-liver phenotype (60 out of 60 morphants) similar to the m198 homozygous mutant at the similar 
stage. The liver in the standard control morphants (49 out of 49 morphants) appeared apparently 
normal.  
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4.4  Discussion 
Positional cloning work successfully pin pointed the mutation site in zebrafish 
liver mutant line 198. The point mutation was revealed to be a thymidine to adenine 
transition in the sixth intron of sec13 gene, which creates a new pre-mRNA splicing 
site and therefore eight excessive nucleotides were introduced to the mutant mRNA. 
The final gene product in the mutant is predicted to be a carboxyl-terminal truncated 
protein because of the frame-shift caused by the excessive eight base pairs. The 
relationship between the mutation and the phenotype was confirmed by sec13 mRNA 
rescue experiment and by knock-down experiment with a splicing morpholino 
specifically targeting sec13. Thus the mutant line 198 is referred to as sec13sq198 
mutant hereafter.  
In addition to these major results, our positional cloning work produced and 
established some very essential methods and resources for future experiments. For 
instance, two methods can be used for genotyping sec13sq198 conveniently in future 
experiments (listed in Appendix 3). Previously we had to rely on WISH on embryos 
from many crosses to identify heterozygous pairs from an adult population. Now, the 
genomic DNA sequencing methods can be used to accurately identify heterozygous 
pairs. The closely linked markers (257D, 257E, 257H, etc.) can also be used for PCR 
genotyping embryos generated by mapping pairs. All the new SSLP markers 
identified in this part will no doubt enrich current zebrafish genetic marker collections 
and have a potential to benefit future gene mapping work on linkage group 22 in 
zebrafish.  
The sec13 gene is known to be a component in the conserved COPII complex, 
which is responsible for the vesicle transport of newly synthesized proteins from 
endoplasmic reticulum (ER) to Golgi apparatus (Tang et al., 2005). According to the 
latest model, Sec13 interacts with its partner Sec31 to form the basic assembly unit of 
the COPII cage. Since 1/4 of the carboxyl-terminal of the Sec13 is truncated in 
sec13sq198 mutant (Figure 4-10), its interaction with Sec31, the subsequent formation 
of COPII complex and the COPII mediated ER transport could be probably affected.  
Although numerous works have been conducted on the COPII complex in the 
yeast and in human cell line, it has rarely been studied in multicellular organism 
model, especially its role in organogenesis. Only two recent articles suggested that 
sec23a, another component of the COPII complex, is genetically linked with human 
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cranio-lenticulo-sutural dysplasia (CLSD) syndrome and a sec23a loss-of -function 
mutation causes impaired skeleton cartilage formation in zebrafish (Lang et al., 2006; 
Boyadjiev et al., 2006). Thus our mutant would be the first vertebrate model which 
links the COPII complex with liver development and organogenesis. 
To find out what lies between the mutation and the phenotypes of sec13sq198 
mutant, it is essential to perform detailed characterization work and also study the 
biochemical and structural mechanism behind it, which will be discussed in the 
following chapters.  
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Chapter 5. Phenotype characterization of sec13sq198 mutant 
5.1  Introduction 
Chapter 4 described the work of successful positional cloning of zebrafish 
sec13sq198 mutant gene. The small liver phenotype is genetically linked to a point 
mutation in sec13 gene. Although the purpose in genetic screening was to find 
zebrafish mutants with liver defects, we could not exclude the possibility that the 
mutation also causes phenotypes in other tissues or organs, especially when sec13 is 
known to be a structural component of the conserved COPII complex which is 
supposed to be expressed in all kinds of cell types. This chapter is going to introduce 
the detailed phenotype characterization work on sec13sq198 mutant, which could give 
us a more complete view of the effects of the mutation and guide the following 
mechanism study. 
 
5.2  Materials and methods  
The major materials and methods are described in detail in chapter two.  
The information of RNA probes used in whole mount in situ hybridization during 
the characterization is listed in Appendix 1. 
Embryos were genotyped by sequencing the PCR products amplified from the 
genomic DNA using primers listed in Appendix 3. 
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5.3  Results 
5.3.1 General appearance of the sec13sq198 mutant 
By direct observation of live embryos under a dissection microscope, no 
significant difference could be found in 2 dpf or earlier embryos collected from 
sec13sq198 heterozygous crosses. At 3 dpf, the mutants become recognizable by their 
slightly smaller head, shorter body length, slimmer trunk and bigger yolk as compared 
with the rest of the siblings. These differences become more apparent at 4 dpf and 5 
dpf. In addition, sec13sq198 mutants never form inflated swimming bladder or 
expanded intestinal bulb after 4 dpf. Other differences in general appearance between 
mutants and wild-types can also be observed in their eyes and ear capsules (Figure 
5-1).  
The mutants younger than 5 dpf have normal heart bumping and blood circulation. 
However, they are not as active as the siblings, probably due to the un-inflated 
swimming bladder. At 5 dpf, the mutants failed in forming an opening mouth (by 
observation), which makes them unable to feed themselves. As a result, they become 









Figure 5-1. General appearance of sec13sq198. Green arrow, liver; blue arrow, ear capsule; red 
arrow, swimming bladder; pink arrow, intestinal bulb.  
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5.3.2 Phenotype in digestive organs 
5.3.2.1  Liver specification and budding are not affected in the 
homozygous mutant 
The genetic screening was carried out at ~3 dpf, in which the homozygous mutant 
was found to have smaller liver phenotype. In the phenotypic characterization, the 
first question we would like to ask is that at what stage the liver phenotype starts to 
appear. 
We firstly compared the liver specification and budding in mutant and wild-type 
by checking the expression pattern of two early hepatic markers, prox1 and hex, at the 
stage when liver just finished specification and started migration and budding (~30 
hpf). From the result we could not find any discernible difference between 
homozygous mutants and siblings. This result indicated that the sec13sq198 mutation 
does not affect liver linage specification, hepatoblast migration as well as initial 
budding in zebrafish (Figure 5-2).  
 
5.3.2.2  sec13sq198 Mutant has normal endoderm differentiation  
The liver and other major digestive organs are all originated from the endoderm. 
In zebrafish, the lineage specification of these organs has been finished by 2 dpf. We 
investigated the phenotype of these endoderm-derived organs by in-situ hybridization 
with early endoderm differentiation marker prox1, foxa1, gata6, pdx1 and shh at 2 dpf 
mutant and wild-type embryos. With the help of these markers, we observed no 
significant difference between homozygous mutants and siblings (Figure 5-3). These 
results suggested that the mutation does not affect the differentiation of endoderm by 

















Figure 5-2. Liver specification is not affected in sec13sq198. All the embryos were genotyped 










Figure 5-3. sec13sq198 has normal endoderm differentiation at 2 dpf. All the embryos were 







Figure 5-3. sec13sq198 has normal endoderm differentiation at 2 dpf. All the embryos were 
genotyped after in situ. Red arrow, liver bud., yellow arrow, pancreas bud., blue arrow, intestine. 
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5.3.2.3  Mutant is arrested at expansion growth in digestive organs 
at 3 dpf  
After 2 dpf, the zebrafish digestive organs will undergo rapid proliferation and 
growth, which results in tremendous size increase. To investigate the mutation’s 
effects on organ expansion growth, we conducted in situ hybridization with organ 
specific markers on 3 dpf and 4 dpf wild-type and mutant embryos (Figure 5-4, A and 
B). With the help of the TG (lfabp:rfp;elaA:gfp) transgenic zebrafish (Wan et al., 
2006; Her et al., 2003), we also investigated the liver and pancreas phenotype in live 
embryos at 5 dpf (Figure 5-4-C).  
The results indicated that the expansion growth of the liver, the intestine and the 
exocrine pancreas is largely arrested in homozygous mutants. There seems no size 
increase in the liver after 3 dpf. However, despite the smaller size, the mutant liver 
was seen to migrate normally form left side to right side as that occurs in the 
wild-type liver. The pancreas does not extend from anterior to posterior after 3 dpf. 
Compared with the liver and the pancreas, the intestine is less affected by the 
mutation. Its size increases significantly from 3 dpf to 4 dpf. The gut looping is 
normal in mutant as observed from dorsal view. The intestinal microvillus could also 
be observed in the mutant at 5dpf (Figure 5-5). However, as indicated previously 
(Figure 5-1), the mutant does not form a fully expanded intestinal bulb. In addition, 






Figure 5-4-A. sec13sq198 is arrested at expansion growth of digestive organs. A. Phenotype of 











Figure 5-4-b. sec13sq198 is arrested at expansion growth of digestive organs. B. Phenotype of 








Figure 5-4-c. sec13sq198 is arrested at expansion growth of digestive organs. C. Phenotype of 




















Figure 5-5. TEM image of intestinal epithelium. As indicated by the green arrow, the intestinal 
microvillus is present in the sec13sq198 mutant, which indicates a normal differentiation of intestinal 
epithelium. Scale bar: 1μm. 
  109
5.3.3  Phenotype in other tissues and organs 
5.3.3.1  The sec13sq198 is also impaired in formation of the skeleton 
cartilage 
As previously described, the mutants exhibit a small-head phenotype from 3 dpf 
onwards and are not capable to start self-feeding at 5 dpf. These observations 
indicated that the mutants may have some defects in skeleton and jaw formation. We 
conducted alcian blue staining on 4 dpf and 5 dpf embryos and revealed that the 




Figure 5-6. Defects in cartilage formation in sec13sq198 revealed by alcian blue staining. At 4 
dpf and 5 dpf, the jaw (pink arrow) and the six pairs of branchial arches (red numbers) are clearly 
observable in wild-type but not in the mutant embryos. Besides, the pectoral fin in the mutant is smaller 
than that in the wild-type.  
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5.3.3.2  Blood vessel and pronephric duct are not obviously affected 
by the mutation  
To evaluate the mutation’s effects on some mesoderm derived organs and tissues, 
such as blood vessel and pronephric duct, alkaline phosphatase staining was 
conducted on 4 dpf embryos to illustrate these organs (Figure 5-6). From the result we 
could not find obvious distinguishable phenotypes in these organs and tissues between 
the wild-type and mutant.  
 
 
Figure 5-7. 4 dpf alkaline phosphatase staining. A. Somites and blood vessels on the trunk (red 
arrow) appear normal in the sec13sq198 mutant. However, the coverage of ventral peripheral blood 
vessels in the mutant is reduced. B. sec13sq198 mutant has a smaller anterior region of pronephric duct, 
while the posterior region of the pronephric duct appears normal. Green arrow, blood vessel; red arrow, 
somite. Blue arrow, pronephric duct  
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5.4  Discussion 
Endoderm organogenesis starts from gastrulation stage and includes a series of 
cell linage specification, bud formation, organ expansion, and cell differentiation 
(Zaret, 2002; Wells and Melton, 1999). Investigation of major endoderm organs, 
including intestine, pancreas, and liver, in the sec13sq198 mutant by direct observation 
and using organ-specific molecular markers indicated that these digestive organs 
appear normal until 2 dpf, suggesting that sec13 is not involved in or at least does not 
play major roles for the initiation and budding of digestive organs. However, these 
digestive organs start to become hypoplastic from 3 dpf, including an unexpanded 
intestinal bulb, a smaller liver and pancreas, and an uninflated swim bladder, whereas 
mesoderm-derived organs including somites, blood vessels, and pronephric ducts 
appear relatively normal. The presence of intestinal microvillus and the expression of 
molecular markers specific to fully differentiated intestinal epithelial cells (ifabp), 
hepatocytes (lfabp), and exocrine pancreas (trypsin) in the mutant fish demonstrated 
that cell differentiation is not abolished by the sec13sq198 mutation. The normal liver 
migration and gut looping after 4 dpf suggested that the organ positioning and 
arrangement is not affected by the sec13sq198 mutation despite the significant growth 
arrest.  
The malformed skeleton in the sec13sq198 mutant is quite similar to the phenotype 
observed in the zebrafish crusher mutant, in which a sec23a null mutation causes 
severe reduction of cartilage extracellular matrix (ECM) deposits in chondrocytes, 
including type II collagen (Lang et al., 2006). Considering that Sec13 is one of the 
core structural components of the COPII complex and Sec13sq198 is carboxyl-terminus 
truncated, it is quite possible that in the sec13sq198 mutant, the proper ER to Golgi 
transport is disrupted. If that is the case, the arrested growth of digestive organs could 
be explained in the following ways. Firstly, as that happens in the chondrocytes of the 
crusher mutant, the mis-transportation of certain structural proteins in sec13sq198 will 
no doubt cause abnormal cell activities, such as growth and dividing. Secondly, the 
disrupted protein secretion will probably affect the intracellular signal transduction 
and also cell autonomous regulation, both of which are important in the differentiation 
and growth of endoderm-derived organs as introduced before. Besides, possible 
defects in nuclear pore complex (NPC) may also contribute to the mutant phenotype 
as Sec13 is a known nucleoporin (Loiodice et al., 2004; Boehmer et al., 2003). 
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The next chapter will introduce the efforts to decipher the correlation between the 





Chapter 6. Study of the Sec13sq198 mutant protein at the cellular 
and biochemical levels 
6.1  Introduction 
Previous two chapters introduced the positional cloning work and detailed 
phenotype characterization of zebrafish sec13sq198 mutant. The results indicated that a 
point mutation in zebrafish sec13 gene leads to digestive organ hypoplasia as well as 
skeleton cartilage malformation. From the results a number of questions can be raised. 
For example, how does the mutation in such an essential pathway only seems to cause 
defects in a small group of organs or tissues? Why are the homozygous mutant 
embryos younger than 2 dpf apparently not affected by the mutation? Does Sec13sq198 
totally lost its function or just partially lost. This chapter will describe our efforts to 
answer these questions via molecular and cellular methods.  
Among the five core COPII components, four have been found to have multiple 
functions. As introduced before, Sar1 initiates the vesicle budding and triggers vesicle 
fission. In addition, it is also involved in cargo protein binding and selection together 
with Sec24. Sec23 recruit Sec13/Sec31 heterotetramer to the ERES site via physical 
interaction with Sec31. In addition, Sec23 is a Sar1 specific GTPase activator whose 
activity is exemplified upon the recruitment of Sec13/Sec31 complex and catalyzes 
the Sar1-GTP hydrolysis before vesicle fission. The homologs of all these four 
proteins have been found in eukaryotes, such as yeast and human. A recent gene 
expression profiling study revealed that these homologs exist in different 
concentrations and combinations in a variety of human cell types, which is consistent 
with the distinct requirement of protein secretion pathway in different tissues and 
organs (Gurkan et al., 2006).  
Unlike the other four COPII components, no functional Sec13 homolog has been 
revealed so far and its role in the COPII complex is rather simple. According to the 
latest structural model, Sec13 interacts with Sec31 to form the basic assembly unit of 
the COPII cage (Fath et al., 2007). This interaction between Sec13 and Sec31 works 
in a stabilizing manner because physical interactions in the linker within the basic 
assembly unit or in the vertices of COPII cage are all made by Sec31 subunits. It is 
thus obvious that the relationship of Sec13 and Sec31 in zebrafish would be the 
critical point of the mechanism study of the sec13sq198 mutant. 
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6.2  Materials and methods 
General materials and methods are introduced in Chapter 2.  
Rabbit polyclonal antibodies against human Sec13 and Sec31A, were kindly 
provided by Ms Ong Yanshan, IMCB (Tang et al., 1997; Tang et al., 2000). Mouse 
anti-serum against zebrafish Sec13 was produced in our Monoclonal Antibody Unit 
(MAU, IMCB) by immunizing mouse with in vitro translated zebrafish Sec13. The 
monoclonal antibodies against human β-tubulin, the HA-tag and the Myc-tag were 
purchased from Sigma.  
 
6.3  Results 
6.3.1 Sec13sq198 is a carboxyl-terminal truncated protein 
Based on the sequence information, sec13sq198 mRNA should encode a 
carboxyl-terminal truncated protein which has smaller molecular weight as compared 
to wild-type Sec13. To confirm this predication, protein samples prepared from 5 dpf 
wild-type embryos and 5 dpf homozygous sec13sq198 mutant embryos were subjected 
to western blot analysis. A mouse anti-Sec13 serum recognized two specific bands, 
which were in accordance with the predicated molecular weight of Sec13 (35.24 kd) 
and Sec13sq198 (29.51 kd). The mouse serum also recognized a strong unknown origin 










Figure 6-1. Sec13sq198 is a truncated protein. Protein samples (from 5 dpf embryos) were 
equally loaded. The two specific bands recognized by the mouse serum are indicated by yellow arrows. 
Their apparent molecular weight is in accordance with the predicted molecular weight of Sec13 and 
Sec13sq198. The green arrow indicated a strong band of unknown origin. 
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6.3.2 Expression pattern of sec13 and sec31A in zebrafish 
The initial step to study a gene’s function usually starts from revealing its 
expression pattern. We firstly investigated the temporal and spatial expression 
patterns of sec13 mRNA levels at different developmental stages by northern blot 
analysis and whole mount in situ hybridization. Figure 6-2 represents the northern 
blotting results of sec13 mRNA expression. The result obtained suggests that sec13 
mRNA is maternally deposited and its expression span early embryonic stages in 
unfertilized eggs (maternal) and embryos from 1 dpf to 5 dpf. Whole mount in situ 
hybridization (Figure 6-3) showed that sec13 ubiquitously distributed in unfertilized 
egg. After fertilization, sec13 is evenly distributed into newly formed cells after first 
two rounds of cell division. At 1 dpf, sec13 mRNA was seen to ubiquitously express 
in head and trunk. At 2 dpf and 3 dpf, sec13 continues to express in the head and 
trunk, and is also obviously enriched in the developing digest organs, such as the liver, 
the intestine and the pancreas. At 4 dpf and 5 dpf, strong sec13 mRNA expression is 
apparently enriched in the intestine and meanwhile, weak but still distinguishable 











Figure 6-2. sec13 expression during embryogenesis. 15 μg of total RNA was loaded to each 





Figure 6-3. sec13 expression pattern. l: liver; p: exocrine pancreas; i: intestine; c: cartilage. 
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Secondly, we studied the temporal protein expression pattern of Sec13 as well as 
its known interaction partner Sec31A (Shugrue et al., 1999; Tang et al., 2000) via 
western blot analysis. As shown in Figure 6-4, Sec13 is maternally deposited and 
could be detected consistently in all stages investigated, which is consistent with its 
mRNA expression (Figure 6-2 and 6-3). However, Sec31A is not detectable in 
maternal and 1 dpf zebrafish protein samples. Sec31A is weakly detected at 2 dpf, 
gradually displayed strong and consistent signals from 3 dpf afterwards.   
 
 
Figure 6-4. Temporal expression pattern of Sec13 and Sec31A. A anti-β-tubulin antibody was 
included as the loading control.   
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6.3.3 Sec13 and Sec31A co-localized in a variety of cell types in 
zebrafish 
Previous studies have demonstrated that the most essential function of Sec13 in 
COPII complex is to form the outer layer coat together with Sec31 (Fath et al., 2007). 
In yeast and human cell line, Sec13 was found to be co-localized with Sec31 in ER 
membrane (Tang et al., 1997; Tang et al., 2000). To reveal whether this phenomenon 
also exists in zebrafish, we performed immuno-staining in zebrafish sections with an 
anti-Sec13 mouse serum and an anti-Sec31A polyclonal antibody (rabbit). 
The immunofluorescence experiment was firstly conducted in sections collected 
from 5 dpf wild-type zebrafish embryos. The result showed that in zebrafish, Sec13 
and Sec31A are expressed in a variety of tissues and cells. High levels of 
co-localization pattern of these two proteins could be easily observed in the liver, the 
intestine, the exocrine pancreas and the cartilage cells (Figure 6-5, A and E). However, 
the Sec13 signal is absent in the islet (Figure 6-5, A and C). At single cell level 
(Figure 6-5, B-D), the co-localization pattern above is quite similar to that previously 
observed in yeast and human cell line (Tang et al., 2005; Tang et al., 2000). 
Furthermore, the co-localization in the intestinal epithelial cells only restricted to the 
luminal side, which is a good indication that Sec13 and Sec31A are involved in the 
secretive pathways in zebrafish. 









Figure 6-5. Sec13 is co-localized with sec31A in wild-type zebrafish. (Red arrow, liver, green 












Figure 6-5. Sec13 is co-localized with Sec31A in wild-type zebrafish. A, B, C and D are 
confocal planes from the same wild-type zebrafish cross-sectioning through the islet. These images 
indicate that Sec13 and Sec31A expressed in a variety of organs and tissues (A). These two proteins are 
co-localized in the liver (B), the intestine (D) and the exocrine pancreas, but not the islet (C), in which 
Sec13 signal is not observable. The co-localization in intestine occurs strictly in the luminal side of the 
intestinal epithelium. E is a confocal plane cross the head. As indicated by the image, sec13 and 
sec31A highly express and localize in the skeleton cartilage cells (pink arrow). The co-localization 
pattern in single cell level in this study (B, C, D and E) is similar to those previously observed in yeast 
and human cell line. (Red arrow, liver, green arrow: intestine; yellow arrow: exocrine pancreas; white 
arrow: islet. pink arrow) 
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The same experiment was also performed on 5 dpf sec13sq198 mutant sections. 
However, the co-localization pattern in the mutant could not be evaluated due to the 
weak signal from the anti-Sec13 mouse serum (Figure 6-6), which is probably a result 
of the preference of this anti serum to the carboxyl-terminal region of the Sec13 in 
tissue slides.  
 
 
Figure 6-6. Immunofluorescence of Sec13 and Sec31A in mutant section. These images are 
derived from a confocal plane of a 5 dpf sec13sq198 mutant embryo cross-section. Sec31A expression is 
comparable with that observed in wild-type sections. Sec13sq198 signal is almost un-detectable by the 
mouse anti-sec13 serum.  
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6.3.4 Sec13sq198 fails to form a complex with Sec31A 
Sec13sq198 is a carboxyl-terminal truncated Sec13. To find out if the lost 
carboxyl-terminal of Sec13 is important for forming the coat complex with Sec31, we 
carried out the following experiments in human Hela cell and 293T cell. The human 
cell line system was chosen because of the high homology between the human and 
zebrafish homologs of Sec13 and Sec31A (Figure 6-7 and Figure 6-8). We created a 
human form of the zebrafish sec13sq198 by inserting the eight excessive nucleotides of 
zebrafish sec13sq198 mRNA into the comparable region of a human sec13 cDNA via 
PCR method. The wild-type and the mutant cDNAs, both zebrafish and human, were 
cloned into PD-HA and PD-Myc eukaryote expression vectors and then used to 
transfect human cells mentioned before.  
 
 
Figure 6-7. Protein sequence alignment of zebrafish and human Sec13.  Human (accession 







Figure 6-8. Protein sequence alignment of zebrafish and human Sec31A. A. The domain 
structure of Sec13 and Sec31, taken from Fath et al., 2007. B. Human (accession number: 
NP_001070675) and zebrafish (accession number: Q7SYD5) Sec31A share high level of homology in 
their β-propeller region and α-solenoid region, which are essential for the formation of the basic 
assembly unit of COPII complex (Fath et al., 2007). The anti-Sec31A antibody used in this study was 
raised against the last 180 amino acid of human Sec31A (Tang et al., 2000). 
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6.3.4.1  Sec13sq198 fails to co-localize with Sec31A in vivo 
To study the interaction of Sec13sq198 and Sec31A in vivo, the Myc-tagged human 
Sec13 and Sec13sq198 mimicking constructs were transfected into Hela cells. 
Immunofluorescence experiment was then conducted to investigate the expression 
pattern of endogenous Sec31A and the over-expressed exogenous Sec13 and 
Sec13sq198 proteins. The results indicated that Myc-tagged human Sec13 enriched 
predominantly around nuclear membrane and perfectly co-localized with endogenous 
Sec31A (Figure 6-9-A), which is quite similar to the reported co-localization pattern 
of endogenous Sec13 and Sec31A in normal rat kidney (NRK) cells (Tang et al., 
2005). The same co-localization pattern was also observed in cells transfected with 
Myc-tagged zebrafish Sec13 construct (Figure 6-9-C), which suggested that zebrafish 
Sec13 is a functional ortholog to human Sec13. However, the co-localization pattern 
was totally lost in cells transfected with Sec13sq198 mimicking construct (Figure 










Figure 6-9. Sec13 and Sec31A interaction in Hela cells. A. the Wild-type mimicking 
Myc-humo-Sec31 co-localized with endogenous Sec31A in Hela cell. B. The mutant mimicking 
Myc-humo-198 failed to co-localize with endogenous Sec31A in Hela cell. C. The Myc-danio-Sec13 
co-localized with endogenous Sec31A in Hela cell.  
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6.3.4.2  Sec13sq198 fails to be immunoprecipitated with Sec31A 
In addition to the in vivo study in Hela cell, co-immuoprecipitation (Co-IP) study 
was also carried out in 293T cells to investigate the interaction between exogenous 
Sec13sq198 and endogenous Sec31A. In brief, the HA-tagged human Sec13 and 
Sec13sq198 mimicking construct were transfected into 293T cells respectively. A 
PD-HA vector was included as a negative control. Proteins were extracted from 
transfected cells and Co-IP was performed essentially as described in Chapter 2. A 
rabbit anti-Sec31A antibody and a mouse anti-HA antibody were used to detect 
endogenous Sec31A and the exogenous proteins respectively.  The result suggested 
that the wild-type Sec13 co-immunoprecipitates with endogenous Sec31A while the 
Sec13sq198 fails to do so (Figure 6-10).  
 
 
Figure 6-10. Co-immunoprecipitation of Sec31A and Sec13 in 293T cell. The HA tagged 
human wildtype Sec13 co-immunoprecipitates with endogenous Sec31A. While he HA tagged 







6.3.5 sec13sq198 mutation disrupted the secretory pathway 
The study of the zebrafish crusher mutant revealed that loss of function of Sec23a, 
another core COPII component, disrupted the secretory pathway in chondrocytes. The 
crusher chondrocytes accumulate protein in a distended ER, leading to severe 
reduction of extracellular matrix (ECM) deposits (Lang et al., 2006). Since sec13 was 
found to be highly expressed in chondrocytes and the sec13sq198 mutant has a 
phenotype of impaired skeleton cartilage quite similar to the crusher mutant, we 
conducted transmission electron microscopy (TEM) on chondrocytes of 5 dpf 
wildtype and sec13sq198 mutant embryos.  
The TEM results indicated that sec13sq198 mutant has abnormal cartilage cells as 
compared with wildtype. The ECM of sec13sq198 mutant chondrocytes is significantly 
less dense than that in the wildtype (Figure 6-11). On the other hand, the mutant 
cytosol is filled with numerous vesicles containing electron dense material (green 
asterisks in Figure 6-11-c; Figure 6-12, d), which may represent undelivered protein 
cargo. The Golgi body and rough ER (Figure 6-12, a and b) could be easily identified 
in the wildtype chondrocytes but not in the mutant, which indicates a malfunction of 
the secretory pathway and is consistent with a previous model that Golgi function 
depends on COPII and COPI mediated membrane recycling (Bonfanti et al., 1998; 
Presley et al., 1997). In the wildtype chondrocytes, small vesicles (Figure 6-12-c) 
resembling conventional COPII cages (Salama et al., 1993; Lederkremer et al., 2001; 
Antonny et al., 2003) in size and shape could be found between rough ER and the 
Golgi body. However, this phenomenon was never observed in cross-cartilage 








Figure 6-11. sec13sq198 mutant has malformed chondrocytes and abnormal ECM deposition. 
e: ECM; *: vesicles containing electron dense material. Scale bars in a and c: 5 μm; Scale bars in b 





Figure 6-12. sec13sq198 chondrocytes has abnormal ER and Golgi formation. Blue arrow: 
Golgi body. Green arrow: rough ER; red arrow: putative COPII vesicle. Scale bar in a: 0.5 μm; scale 










Figure 6-12 sec13sq198 chondrocytes has abnormal ER and Golgi formation. Scale Bar: 0.5 μm 
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6.4  Discussion 
This chapter presented the mechanismic study of the zebrafish sec13sq198 mutant 
at the cellular and biochemical levels.  
The western blot analysis of zebrafish protein samples prepared from both 
wild-type and mutant embryos confirmed the product of predicted carboxyl-terminus 
truncation of Sec13 in the sec13sq198 mutant. In wild-type embryo, both sec13 mRNA 
and protein are maternally deposited and their expression levels are consistent in all 
developmental stages checked. These results indicated that sec13 is essential for early 
stages of embryogenesis and in the sec13sq198 mutant, the maternal deposit can 
possibly compensate the loss of zygotic wild type sec13 in early stages. On the other 
hand, its essential partner Sec31A is not maternally deposited and its expression starts 
only after 3 dpf. The combination of these could probably help explain why the 
observable phenotypes of sec13sq198 mutant become apparent from 3 dpf onwards. 
Whole mount mRNA in situ hybridization experiment revealed that sec13 mRNA is 
ubiquitously expressed through out the zebrafish embryo at all stages checked. 
However, high expression level of sec13 mRNA could be observed in digestive 
organs after 2 dpf, which is consistent with the fact that the mutation mainly affects 
the growth of these organs. Trace amount of sec13 mRNA could also be detected in 
the skeleton cartilage (Figure 6-3, black arrow in 4 dpf embryo). This probably does 
not reflect the actual expression level because the thick extracellular matrix (ECM) of 
the chondrocytes may limit the penetrance of the probe.  
The interaction of Sec13 and Sec31A in zebrafish at the cellular level was 
investigated by immunofluorescence experiments. The results indicated that although 
Sec13 and Sec31A have generally distinct distribution patterns in zebrafish tissues, 
they are co-localized in the liver, the intestine, the pancreas as well as the skeleton 
cartilage, indicating that these two partners play important functions in these organs. 
At the cellular level, the co-localization pattern in these organs is quite similar to that 
observed in the yeast and mammalian ER membrane, which reflects the conserved 
function of COPII complex. However, only Sec31A signal could be detected in the 
islet while Sec13 signal is almost absent. This could probably explain why the islet is 
not affected in the sec13sq198 mutant.  
In the sec13sq198 mutant, the co-localization pattern of these two proteins is likely 
disrupted due to the carboxyl-terminus truncation in Sec13sq198. However, we failed in 
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demonstrating this directly from zebrafish sections, probably due to the 
carboxyl-terminus preference of the anti-Sec13 mouse serum in frozen sections. 
Nevertheless, in human cell line, we demonstrated indirectly that Sec13sq198 lost its 
affinity with Sec31A in vivo. 
To evaluate the effect of the sec13sq198 mutation in cellular level, we conducted 
transmission electron microscopy on thin sections cross 5 dpf mutant and wildtype 
skeleton cartilage. The results revealed a misplacement of ECM and a disrupted ER 
and Golgi structure in mutant chondrocytes, which indicated a defected secretory 
pathway. 
Combine all data in our hands, we propose that the loss-of-function mutation in 
sec13sq198 mutant disrupts the proper protein transportation via COPII cage in 
zebrafish embryo and that causes the growth arrest in the liver, the intestine, the 
pancreas as well as the skeleton cartilage. Our study is so far the first report that sec13 
and the COPII complex are involved in organogenesis.  
To make our study more complete, we need to address a few questions in the near 
future. For example, both increased apoptosis and decreased proliferation could 
contribute to arrested organ growth. Since the sec13sq198 has normal endoderm 
differentiation, the involvement of these two pathways in the mutant phenotype need 
to be investigated. In addition, our immunostaining experiment did not produce high 
quality image regarding the subcellular localization of Sec31A in mutant sections, 
which could be essential in implicating whether COPII cage formation is Sec13 
dependent or not. This experiment would be more convincing if we can include other 





Chapter 7. Phenotype characterization of the defhi429 mutant 
 
7.1  Introduction 
In addition to the work on the sec13sq198 mutant, I was also once involved in the 
defhi429 mutant project (Chen et al., 2005) in Dr Peng’s lab. My major contribution in 
the defhi429 project is the detailed characterization of the mutant phenotype.  
 
7.2  Materials and methods 
General materials and methods are introduced in Chapter 2. 
The information of RNA probes used in whole mount in situ hybridization during 
the characterization is listed in Appendix 1. 
The defhi429 mutant was originated from a large-scale insertional mutagenesis 
screen using mouse retroviral vectors as the mutagen (Golling et al., 2002) and was 
kindly provided by Professor Nancy Hopkins at Massachusetts Institute of 
Technology (Cambridge, MA) (Gaiano et al., 1996).  
 
7.3  Results 
7.3.1 Major digestive organs in the defhi429 mutant are severely 
hypoplastic. 
By direct observation under a dissection microscope, the homozygous defhi429 
mutant appears normal up to 3 dpf. At 5.5 dpf, the defhi429 mutant is recognizable for 
its large unabsorbed yolk sac, smaller liver, pancreas and swimbladder and much 
slimmer intestine as compared with the siblings (Figure 7-1). Phenol Red injection at 
5 dpf revealed that in addition to the defects, the defhi429 mutant has a smaller 
gallbladder and under-expanded intestinal bulb (Figure 7-2). The defhi429 mutant dies 








Figure 7-1. General appearance of 5.5 dpf defhi429 mutant. Red arrow: liver; blue arrow: 









Figure 7-2. Gallbladder and intestinal bulb of 5 dpf defhi429 mutant. The gallbladder (gb) and 
intestinal bulb (in) were illustrated by phenol red injection.   
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7.3.2 defhi429 mutant has normal digestive organ specification 
The major digestive organs are all originated from the endoderm. In zebrafish, the 
transition of endoderm to the lineage specification of these digestive organs has been 
finished and fully recognizable by 2 dpf. We investigated the phenotype of these 
endoderm-derived organs in the defhi429 mutant by in-situ hybridization with early 
endoderm differentiation marker prox1, foxa3, and pdx1 at 2 dpf and could not 
observe discernible difference between homozygous mutants and siblings (Figure 7-3). 





Figure 7-3. Expression pattern of early endoderm markers in defhi429 mutant. 
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7.3.3 defhi429 mutant is arrested at expansion growth of the digestive 
organs 
As introduced before, the zebrafish digestive organs will undergo tremendous 
size increase between 3-5 dpf. To investigate the effects of defhi429 on organ expansion 
growth, we conducted in situ hybridization with organ specific markers on 3 dpf, 4 
dpf, and 5 dpf wild-type and mutant embryos.  
The results indicated that the expansion growth of the liver, the intestine and the 
exocrine pancreas is arrested in homozygous mutants. The mutant liver after 3 dpf is 
only half the size of the sibling. However, despite the smaller size, the mutant liver 
migrate normally from the left side to the right side as that occurs in the wild-type 
(Figure 7-4-A). The pancreas size is also significantly smaller in the mutant from 3 
dpf onwards. In contrast, the islet size and signal intensity of insulin in the mutant and 
wildtype is indistinguishable in all stages checked (Figure 7-4, B and C). The gut 
looping is normal in the mutant as observed from the dorsal view. However, 
consistent with direct observation of live embryos, the mutant does not form a fully 
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Figure 7-4. Arrested digestive organs in defhi429 mutant. Intestine development in defhi429 
mutant as revealed by ifabp expression. 
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7.4  Discussion 
Endoderm organogenesis is a complicated process and consists stages of cell 
linage specification, bud formation, organ expansion, and cell differentiation (Wells 
and Melton 1999; Zaret 2002). Examination of major endoderm derived organs 
including intestine, pancreas, and liver in the defhi429 mutant using organ-specific 
molecular markers and histological analysis showed that these organs appeared 
normal till 2 dpf, suggesting that Def is not essentially involved in the initiation and 
budding of digestive organs. However, digestive organs start to become hypoplastic 
from 3 dpf, including an underdeveloped gut tube and a smaller liver, gall bladder, 
pancreas, and swimbladder, whereas mesoderm-derived organs including somites, 
blood vessels, and pronephric ducts appeared normal. The underdevelopment of the 
entire digestive system in the defhi429 mutant could probably result from the arrest of 
cell proliferation as found for the nil per os (npo) mutant (Mayer and Fishman, 2003). 
Although at a relatively lower level and reduced range, when compared with the 
wild-type control, molecular markers specific to fully differentiated intestinal 
epithelial cells (ifabp), hepatocytes (transferrin), and exocrine pancreas (trypsin) are 
expressed in the mutant fish, demonstrating that cell proliferation is normal in the 
defhi429 mutant. The characterization results strongly suggest that def may function as 
a cell-autonomous factor to regulate the expansion growth of various digestive organs 
except the endocrine pancreas at the later stage of endoderm organogenesis. 
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Chapter 8. General Conclusions and Future Prospects 
 
The primary purpose of this research project is to use zebrafish as the model to 
study liver development. The accomplished work consists three parts. 
The first part of the project was to maintain and confirm 71 liver defective 
zebrafish mutants obtained from initial mutant screening. Finally, 67 out of the 71 
mutant lines were confirmed. Based on their liver phenotype and general appearance, 
only 15 individual mutant lines with minor general defects were finally selected to 
keep. These mutants may serve as invaluable materials to study liver development. 
The second part of the project was to identify the genetic lesion in the mutants via 
positional cloning approach. In my study, a mutant line (sec13sq198) with small-liver 
phenotype was selected for positional cloning work. The mutation was finally 
revealed to be a thymidine to adenine transition in the 7th intron of sec13 gene. It 
creates a new splicing receptor site and induces 8 excessive nucleotides into the final 
mRNA product, which encodes in a carboxyl-terminal truncated protein. The 
correlation of the mutation with the phenotype was confirmed by mRNA rescue and 
morpholino mimicking experiments.  
The third part of the project was to reveal the mechanism that the mutation causes 
the phenotype. The detailed mutant phenotype characterization work revealed that the 
mutation has no significant effect on embryonic development prior to 2 dpf but it 
causes growth arrest in the liver, the intestine, the pancreas and the skeleton cartilage 
after 3 dpf. This mutant phenotype was reflected in and was in consistent with the 
spatial and temporal expression pattern of sec13 as well as its known interaction 
partner sec31A in zebrafish embryo. Cellular localization study in zebrafish sections 
revealed that Sec13 and Sec31A are highly expressed in the tissues and organs that 
affected by the sec13sq198 mutation. Mimicking experiment in human cell line showed 
that the Sec13sq198 lost its co-localization and direct interaction with Sec31A. TEM on 
thin sections cross skeleton further confirmed malfunction of secretory pathway in 
mutant chondrocytes. Thus we propose that the point mutation in the zebrafish 
sec13sq198 mutant disrupted the formation of COPII cage in zebrafish embryo and 




Although this study proved the involvement of sec13 as well as the COPII 
complex in organogenesis, there are still a lot of work need to done to make this study 
a complete story. Liver development is a complicated process. This project is 
originated from a moderate scaled genetic screening and can only be considered as a 
small step in deciphering mechanisms involved in liver development. We hope that 
the knowledge obtained from both the current and the consequent study from this 




Appendix 1 Molecular probes used in the in situ hybridization 
 
The EST project in our lab (Lo et al., 2003) provided most of the molecular 
probes used in our in situ hybridization. The prox1 plasmid was kindly provided by 
Dr. Liu Yiwen and the rest of the plasmids were obtained via molecular cloning 
approach. 
 
Probe Vector Source Antisense promoter 
foxa1 PKS PJR EST collection Z1 T3 
foxa3 pGEM® T-Easy molecular cloning T7 
gata6 PSK PJR EST collection Z2 SP6 
hex pGEM® T-Easy molecular cloning SP6 
ifabp pGEM® T-Easy molecular cloning SP6 
insulin pGEM® T molecular cloning SP6 
lfabp PKS PJR EST collection Z1 T3 
pdx1 pGEM® T-Easy molecular cloning SP6 
prox1 pGEM® T-Easy molecular cloning SP6 
shh PKS PJR EST collection Z1 T3 
surfactant PSK PJR EST collection Z2 T7 
transferrin pGEM® T-Easy molecular cloning SP6 
trypsin PKS PJR EST collection Z1 T3 
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Appendix 2 Mapping panel 
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To construct the Mapping Panel, 451 SSLP markers were selected from the Zon 
Lab (http://zon.tchlab.org/) and the MGH zebrafish server 
(http://zebrafish.mgh.harvard.edu/). They were tested by PCR method on AB and 
WIK genomic DNA as introduced in Chapter 4. Those 226 that indicated 
polymorphism were selected to make the mapping panel.  
As indicated in the table, the Mapping Panel primers are arrayed in four 96-well 
plates with their names, origin and relative position recorded. The detailed mapping 
information of these markers can be retrieved from the Zebrafish Microsatellite Map 
Server (http://zebrafish.mgh.harvard.edu/zebrafish/index.htm) by inputting in their 
names respectively.  
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Appendix 3 Methods for sec13sq198 mutant genotyping 
 
1. Genotyping via PCR and sequencing 
Zebrafish genomic DNA samples were firstly amplified by PCR using two 
primers (M5A and M3A) flanking the intron 7 of the sec13 gene. Then the PCR 
product was used as the template in sequencing reaction with a nested primer (M3C). 
The genotype can be easily confirmed by analyzing the sequencing trace files as 
indicated in Figure 4-10-B. The sequence information of the genotyping primers are 
listed below 
Name  Sequence 
M5A   5’ AGTGGAAAGAGGACCAGAAG 3’ 
M3A   5’ GATGGGCTCCTTCTATTGGT 3’ 
M3C   5’ GGACCAGCTCACGTGCCA 3’ 
 
2. Genotyping via Mapping PCR and electrophoresis 
During the positional cloning work, several tightly linked genetic markers, such 
as 257D, 257H, and 257E has been identified as introduced in Chapter 4. Among 
these markers, 257D was eventually selected to use in the genotyping of embryos 
generated from mapping pairs via PCR and electrophoresis. 257D produces clear and 
consistent polymorphism between AB and WIK lines in all our mapping families. The 
primer sequences and PCR amplification condition was optimized as following: 
 
Name   Sequence 
257D-forward 5’ AAACGCAGGAATTTGTCCAG 3’ 
257D-reverse 5’ GAGGTTGAATTTGCAGTTTGC 3’ 
 
 
Optimized PCR conditions 
Cycles Condition Comments 
1X 94 ℃, 3 minutes Initial denaturation 
94 ℃, 30 seconds Denaturation 10X 
Starting at 60 ℃ with 1 ℃ 
decrease per cycle, 30 seconds 
Touch-down annealing 
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 72 ℃, 45 seconds Extension 
94 ℃, 30 seconds Denaturation 
55 ℃, 30 seconds Annealing 30X 
72 ℃, 45 seconds Extension 
10X 72 ℃, 10 minutes Final extension 
 
The PCR product was run on high resolution gel (3.5% MS-8 agarose in 0.5X 
TBE) at 8-10 V / cm in 0.5X TBE for 1 hour and 30 minutes. The result was 
interpreted as showed in the image below. The mutant genomic DNA can only 
produce the AB band and the homozygous WIK wildtype genomic DNA only 
produces the WIK band. The heterozygous genomic DNA will produce both the AB 
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